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Abstract 
 
 
Research on addictive behavior has traditionally emphasized the role that primary 
reinforcing effects of drugs of abuse plays in the development and maintenance of dependence. 
However, contemporary behavioral economic theory and animal models of nicotine dependence 
suggest the need for greater attention to the impact that response to alternative rewards may have 
on smoking behavior. The present study sought to investigate the impact of nicotine withdrawal 
on self-report, behavioral and neural indices of motivation, immediate response to rewards and 
the capacity to learn and modify behavior in response to positive and negative feedback. Heavy 
smokers (n = 48) completed two laboratory sessions following overnight deprivation, during 
which they smoked either nicotinized or denicotinized cigarettes. At each session, they 
completed a reward prediction and feedback learning task while electro-encephalographic 
recordings were obtained, as well as resting state recordings which were used to extract global 
indices of motivational state. Results confirmed that nicotine withdrawal produced an avoidant 
motivational state. This effect was strongly related to numerous indices of smoking motivation. 
Exploratory analyses also revealed numerous moderators of these effects. Behavioral data from 
tasks provided some support for the impact of nicotine withdrawal on reward and feedback 
processing, though minimal impact was observed for neural indices. Together, results confirm 
the manifestation of a broad-spanning impact of nicotine withdrawal on motivational state, but 
effects on specific reward systems remains unknown. Future research should examine the impact 
of nicotine withdrawal on other reward-related constructs to better delineate these effects. 
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Introduction 
Following the 1964 Surgeon General’s report on smoking and health (U.S. Public Health 
Service, 1964), research on the health consequences of tobacco use began to grow rapidly. At 
present, strong evidence implicates a role for tobacco smoking in the development of several 
widespread health problems (Centers for Disease Control and Prevention, 2009). These health 
consequences lead to approximately 480,000 deaths in the United States alone each year (U.S. 
Department of Health and Human Services, 2014), with millions more worldwide (Ezzati & 
Lopez, 2003; Murray & Lopez, 1997). Despite monumental efforts to improve interventions and 
reduce the prevalence of smoking, recent estimates indicate that approximately 1 in 5 adults in 
the United States is a current smoker (Centers for Disease Control and Prevention, 2014). 
Although the majority of smokers are interested in quitting and amenable to treatment (Centers 
for Disease Control and Prevention, 2003; M. C. Fiore et al., 2004), even those who undergo 
intensive treatments are highly likely to relapse within 6 months (M.C. Fiore, Jaen, & Baker, 
2008). Nicotine, the primary psychoactive constituent in tobacco, is thought to play a principal 
role in both ongoing smoking behavior and relapse (Benowitz, 1988). A better understanding of 
the role that nicotine plays in maintaining smoking behavior will aid in the development of novel 
interventions for smokers and has the potential to significantly boost cessation rates.  
Traditional Views on Nicotine  
Theories of smoking behavior in humans have routinely emphasized the role of the innate 
pleasurable effects derived from smoking (i.e. positive reinforcement) and the relief of aversive 
2 
withdrawal symptoms experienced during abstinence (i.e. negative reinforcement; Eissenberg, 
2004; Glautier, 2004).  Smoking cessation interventions have typically been developed and 
studied in concordance with these views. For example, pharmacotherapy development has 
focused on identifying medications capable of decreasing the value of nicotine by blocking these 
rewarding effects or mitigating withdrawal symptoms (Benowitz, 2008; Lerman et al., 2002). 
Interestingly, it has been noted that these “primary reinforcing” effects of nicotine are weak 
relative to other drugs of abuse (Henningfield & Goldberg, 1983), despite the fact that nicotine is 
generally considered to be highly addictive and to carry abuse potential comparable to that of 
other drugs (see J. H. Robinson & Pritchard, 1992; Stolerman & Jarvis, 1995). Traditional self-
administration paradigms employed with other drugs (e.g. fixed ratio reinforcement schedules) 
do not reliably result in self-administration of nicotine in primates (Deneau & Inoki, 1967). 
Although rodent studies have produced responding using a fixed ratio schedule, these have 
generally required restricted access, pairing of the drug with other stimuli (i.e. second-order 
conditioning), or other modifications in order to prove successful (Rose & Corrigall, 1997). 
Thus, increases in the incentive value of nicotine (T. E. Robinson & Berridge, 1993, 2000, 2008) 
due to its reinforcing properties appear to offer an important, but incomplete understanding of 
the development and maintenance of smoking behavior. Recent evidence suggests that nicotine 
may generate and maintain addiction through very different mechanisms. 
Alternative Views on Nicotine 
A growing body of literature in rodent models of nicotine dependence suggests that self-
administration of nicotine is maintained primarily via the influence of nicotine on other 
environmental rewards (i.e. "secondary reinforcement"; Chaudhri et al., 2006; Le Foll & 
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Goldberg, 2005), rather than due to the primary rewarding effects themselves. Expanding on 
early work documenting that nicotine self-administration is not always reliably induced with 
prototypical paradigms (as described above), research has revealed that reliable responding can 
be produced when nicotine is paired with other reinforcers. For instance, rodent studies 
demonstrate that when nicotine is paired with a brief cue light, followed by the cage lights being 
dimmed (which itself served as a reinforcer), rats will reliably respond for nicotine under fixed 
ratio conditions (Caggiula et al., 2002). In a related line of work, rodent models indicate that 
nicotine withdrawal reliably increases the neural reward threshold, resulting in the need for 
greater amounts of reward to activate reward pathways (Epping-Jordan, Watkins, Koob, & 
Markou, 1998). These deficits in reward processing are thought to produce a state akin to 
anhedonia, similar to that seen in depression (Paterson & Markou, 2007). It is characterized by 
an inability to experience pleasure and a resultant withdrawal from previously pleasurable 
activities (Loas, 1996). Indeed, the underlying neurobiology of depression and addiction appears 
to be strikingly similar (Balfour & Ridley, 2000; Markou, Kosten, & Koob, 1998). In light of 
evidence suggesting that smokers who show a blunted neural response to positive stimuli may be 
more prone to relapse following a quit attempt (Versace et al., 2012), it is plausible that nicotine 
motivates smoking behavior not only by increasing the incentive value of smoking, but by 
suppressing the value of alternative behaviors. Unfortunately, human research on this topic is 
limited, as reviewed below. 
Nicotine Withdrawal and Anhedonia in Humans  
In one line of research, nicotine withdrawal has produced consistent deficits on the Card 
Arrangement Reward Response Objective Task (CARROT), which measures the change in rate 
that participants perform a simple card-sorting task under conditions of reward and no-reward 
4 
(al-Adawi & Powell, 1997; Dawkins, Powell, West, Powell, & Pickering, 2006; Powell, 
Dawkins, & Davis, 2002). However, one study did find a general decline in performance not 
specific to reward trials, indicating that deficits may be due to generalized cognitive deficits and 
motor performance slowing, rather than blunted reward response per se (Kalamboka, Remington, 
& Glautier, 2009). Other studies have shown that nicotine withdrawal decreases affective 
response to pleasant (Dawkins, Acaster, & Powell, 2007) or both pleasant and unpleasant 
(Dawkins & Powell, 2011) images.  
 Whereas deficits in the immediate reward response during nicotine withdrawal may be 
inherently aversive and/or motivate smoking behavior during withdrawal episodes, it is equally 
important to understand how withdrawal might lead to changes in reward-seeking behavior over 
time due to learning deficits. This is particularly critical given that smoking cessation aids appear 
to mitigate the effects of withdrawal on immediate reward response (Cryan, Bruijnzeel, Skjei, & 
Markou, 2003). Nicotine withdrawal has a remarkably rapid onset, with many effects emerging 
within 30 minutes of smoking (Hendricks, Ditre, Drobes, & Brandon, 2006). Thus, even 
individuals smoking at regular intervals will likely experience frequent bouts of withdrawal 
throughout the day; potentially suppressing their ability to learn the rewarding properties of 
alternative behaviors. Although mixed findings have been observed for the acute effects of 
nicotine on these learning trajectories in humans (Barr, Pizzagalli, Culhane, Goff, & Evins, 2008; 
Perkins, Grottenthaler, & Wilson, 2009), we are aware of only one study examining withdrawal-
induced deficits in reward-seeking (Pergadia et al., 2014). Thus, the need for human research on 
this topic is great. 
5 
Current Study  
The primary goal of the current study is to investigate the effects of nicotine withdrawal 
on three closely related constructs: approach/avoidance motivational state, reward sensitivity, 
and reward-seeking and aversion-avoidance learning. This goal will be achieved through use of 
carefully selected self-report, behavioral, and neural indices assessing each of the above 
constructs. Given one long-term goal of the proposed study and broader research program will be 
to link human research to neurobiological effects observed primarily in rodent models, neural 
indices in humans may prove particularly useful for understanding the mechanisms involved. In 
addition, research in our laboratory has previously revealed that neural indices may be more 
sensitive than behavioral response on overnight abstinence procedures such as the one employed 
herein (e.g. Evans, Park, Maxfield, & Drobes, 2009). 
Motivational State. Consistent with evidence suggesting similar neurobiological 
processes in nicotine withdrawal and depression (Markou et al., 1998), we will examine 
asymmetry in frontal cortical activity thought to index approach/avoidance motivational state 
(Harmon-Jones, Gable, & Peterson, 2010; van Honk & Schutter, 2006). This index has received 
significant attention as a potential endophenotype for depression and other internalizing 
disorders, and has been demonstrated to have a stable trait-like component, while still being 
modifiable by internal states (Thibodeau, Jorgensen, & Kim, 2006). There is limited work 
examining the effects of nicotine withdrawal on cortical asymmetry, particularly with carefully 
controlled experimental procedures. However, available evidence does provide some support for 
the notion that nicotine withdrawal results in a pattern of asymmetry consistent with a more 
avoidant state (Gilbert et al., 1999).    
6 
Reward Sensitivity. An established reward prediction task (Martin & Potts, 2004; Potts, 
Martin, Burton, & Montague, 2006) will be used to assess reward sensitivity. The task was 
modeled from tasks used to elicit dopamine response in the ventral tegmental area (VTA) in 
monkeys (Schultz, Dayan, & Montague, 1997). Prior research in humans has shown that the 
medial-frontal negativity (MFN) event-related potential (ERP) component operates consistent 
with VTA dopamine neurons (Potts et al., 2006). This component exhibits a pattern similar to the 
feedback-related negativity (FRN), which is thought to reflect monitoring of reward 
contingencies by the anterior cingulate cortex (Holroyd & Coles, 2002), an area that receives 
projections from the striatal dopaminergic systems implicated in both reward-learning 
(Nieuwenhuis, Holroyd, Mol, & Coles, 2004) and addiction (Di Chiara & Bassareo, 2007). 
Given ongoing research into the biological substrates of nicotine withdrawal in animal models 
(Johnson, Hollander, & Kenny, 2008), the insight that this task may provide into the neural 
substrates of nicotine withdrawal in humans may aid development of translational models of 
nicotine dependence. 
Feedback Learning. This will be assessed using a well-established probabilistic learning 
task that has been used to study these processes across a range of neurological and psychiatric 
disorders (Chase et al., 2010; Frank, Seeberger, & O'Reilly R, 2004; Grundler, Cavanagh, 
Figueroa, Frank, & Allen, 2009; Waltz, Frank, Robinson, & Gold, 2007). Previous research has 
documented inhibited performance on this task following dopamine depletion via pharmacologic 
manipulation (Frank & O'Reilly, 2006).  While nicotine withdrawal also depletes dopamine, the 
effects are far more diffuse than the targeted drugs that were used in prior research (Kenny & 
Markou, 2001). Thus, it will be important to confirm that nicotine withdrawal does indeed 
produce similar effects as these targeted agents. Genetic polymorphisms associated with 
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dopaminergic systems have also been shown to impact performance in healthy controls (Doll, 
Hutchison, & Frank, 2011; Frank, Moustafa, Haughey, Curran, & Hutchison, 2007). 
Furthermore, this task allows for concurrent recording of ERPs, and previous research has shown 
that FRN amplitude predicts behavioral performance during this task (Frank, Woroch, & Curran, 
2005). Hence, an extensive research literature documents the relationships between this task, and 
biological substrates involved in addictive behavior. As noted above, such tasks can provide a 
framework for the development and refinement of translational models of dependence, guiding 
further research on this topic in both humans and non-human animals.  
A secondary goal of the proposed project will be to examine whether the outcomes of 
primary aims are moderated by any of several variables suggested by prior research, including 
sex (Perkins, Donny, & Caggiula, 1999), working memory capacity (Cools, Gibbs, Miyakawa, 
Jagust, & D'Esposito, 2008; Frank & O'Reilly, 2006), as well as self-reported trait differences in 
nicotine dependence, approach/avoidance motivational tendencies and impulsivity/risk-taking. 
An additional exploratory goal will be to examine the convergent validity between primary 
outcome variables and select variables with more immediate clinical relevance (e.g. self-reported 
withdrawal, craving, mood, subjective value of smoking, smoking topography), in order to better 
understand the external validity of these tasks and inform future research aimed at developing 
interventions that are consistent with the proposed model. 
Aims and Hypotheses. In accordance with the aforementioned goals, the following 
specific a priori hypotheses were made: 1) Nicotine withdrawal will produce a leftward shift in 
frontal alpha power, indicative of an avoidant motivational state; 2) Nicotine withdrawal will 
slow response times to initiate the next trials following a loss, result in decreased neural 
reactivity in response to unexpected rewards and increased neural reactivity in response to 
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unexpected non-rewards; and 3) Nicotine withdrawal will impair approach-based learning 
(indexed by a reduction in accuracy for approach trials during the testing phase of the 
probabilistic learning task), enhance avoidance-based learning (increased accuracy for avoidance 
trials during the testing phase of the probabilistic learning task) and enhance feedback-related 
negativity response during the training phase of the probabilistic learning task. Additional 
exploratory aims of the present study include: 1) testing whether the effects described in each of 
the above hypotheses are moderated by demographic, smoking or other individual difference 
characteristics; 2) examining convergent validity of primary outcome variables with behavioral 
and self-report indices of smoking motivation (e.g. smoking topography, craving, withdrawal, 
mood, ratings of cigarettes). We make no specific hypotheses regarding these effects.  
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Methods 
Experimental Design and Overview  
The present study employed a within-subjects design, wherein participants completed a 
baseline session followed by two counter-balanced experimental sessions in which they smoked 
either nicotine (0.60 mg nicotine yield) or placebo (0.05 mg nicotine yield) cigarettes (i.e. Quest 
1 or Quest 3; Vector Tobacco, Inc.). Each experimental session was preceded by 12 hours of 
smoking abstinence and both participants and experimenters were blind to cigarette contents. 
Primary outcome measures included asymmetry in resting cortical activity (Hypothesis 1), as 
well as behavioral and neural (i.e. event-related potential) responses on two counter-balanced 
computer tasks (Hypotheses 2 and 3). A wide variety of potentially relevant variables were 
collected at baseline for exploratory analyses aimed at determining whether they moderate any of 
the primary outcomes (Exploratory Aim 1). Self-report and behavioral indices of smoking 
motivation were also collected at the experimental sessions to confirm the success of the 
experimental manipulation and determine the extent to which results from primary outcome 
measures converge with established indicators of smoking motivation (Exploratory Aim 2). 
Participants were compensated approximately $110 apiece for completing the study, with the 
exact amount varying across participants and sessions due to the use of task-based incentives, as 
described below. 
Participants  
A total of 75 smokers were recruited from the community via online and newspaper 
advertisements, flyers, and an existing participant database. The initial eligibility determination 
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was made via telephone based on the criteria outlined below, followed by a more detailed 
assessment during their baseline session at the laboratory. Of the 75 smokers who presented for 
the initial appointment, 27 either failed to attend any of the experimental sessions or were 
determined to be ineligible based on the following criteria.  Individuals were required to be 
English-speaking, 18-65 years of age, have smoked ≥ 15 cigarettes per day for at least one year, 
and not be actively attempting to quit at the time of study. Participants completed a urine drug 
screen to ensure freedom from medications/drugs with the potential to impact study outcomes 
(e.g. benzodiazepines, opiates, cocaine, amphetamines, halluncinogens). Female participants 
were also tested for pregnancy, and confirmed that they were not currently breast-feeding or 
planning to become pregnant during the course of their participation. Participants who reported 
significant medical comorbidities (e.g. asthma, high blood pressure, significant head injury 
involving loss of consciousness, Parkinson’s disease, cancer, kidney disease), disabilities (e.g. 
significant visual or hearing impairment), or use of medications (e.g. psychotropic medications, 
beta blockers) that would compromise either the participants’ safety or the validity of the results 
were excluded.  Participants were also asked to report if they had ever been diagnosed with a 
mental health disorder and underwent additional testing to confirm they were free from active 
psychopathology at the baseline session.  
Procedures  
Baseline sessions began with informed consent procedures, followed by breath samples 
to confirm sobriety (BrAC = .000) and smoking status (CO ≥ 10 ppm). Next, urine samples were 
collected to confirm drug abstinence and negative pregnancy status (females). Participants then 
completed a battery of baseline questionnaires consisting of measures described in detail below. 
Afterwards, a brief structured interview (Sheehan et al., 1998) was administered to assess for the 
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presence of exclusionary psychopathology (i.e. depression, mania, psychosis, alcohol/drug 
dependence). Assuming all eligibility criteria were met, participants also completed a brief 
working memory task, and a behavioral task to assess risk-taking propensity. They were then 
paid, scheduled for their experimental session, given abstinence instructions and dismissed.  
 Experimental sessions began with breath samples to once again confirm sobriety (BrAC 
= .000), and compliance with abstinence procedures (CO < 10 or ≤ 50% of the value obtained at 
the baseline session). Initial measures of smoking motivation were obtained and then participants 
were allotted 10 minutes to smoke their first nicotine or placebo cigarette of the session via a 
CReSS topography device (Borgwaldt, Inc.; Hamburg, Germany). Measures of smoking 
motivation were completed again after smoking, as well as ratings of the cigarette and its effects.  
Participants were then fitted with an EEG cap and afterwards completed a second bout of 
smoking, followed by measures of smoking motivation and cigarette ratings. Immediately after 
completing the measures, EEG was recorded at rest for later extraction of frontal asymmetry 
indices. This was immediately followed by either the reward sensitivity or feedback learning 
tasks (counterbalanced across participants). Once the task was completed, a final round of 
smoking occurred followed by the same battery of measures as with previous bouts with the 
addition of a self-report measure of hedonic capacity/anhedonia. Lastly, participants completed 
another bout of resting EEG and the remaining task. 
Primary Outcome Measures 
Motivational State. Eight minutes of resting EEG activity was obtained at each recording 
(two per session) for extraction of frontal asymmetry indices. Each recording was divided into 
eight one-minute segments of eyes-open or eyes-closed recording that occurred in one of two 
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different counterbalanced orders (OCCOCOOC or COOCOCCO). Participants were seated and 
instructed to fixate their eyes at a spot on the wall during eyes open recording.   
Reward Sensitivity. An established reward prediction task was used to assess reward 
processing/sensitivity (Potts et al., 2006). In this task, participants are presented with a sequence 
of stimuli that includes a predictor stimulus (S1), a reward-determining stimulus (S2), and the 
amount of the reward from the present trial plus current bankroll. Stimuli consist of lemons 
(representing no reward) and gold bars (representing reward). On 80% of trials, S1 and S2 are 
identical (i.e. S1 predicts S2). On the remaining trials, prediction is violated by the presentation 
of a different stimulus. Thus, there are a total of four trial types: (1) Expected Reward (S1 = Gold 
Bar; S2 = Gold Bar); (2) Unexpected Reward (S1 = Lemon; S2 = Gold Bar); (3) Expected No-
Reward (S1 = Lemon; S2 = Lemon); and (4) Unexpected No-Reward (S1 = Gold Bar; S2 = 
Lemon).  A reward ($0.25) occurs if S2 is a gold bar, regardless of S1. Participants “spend” 
$0.05 for each trial. Both the S1 and S2 stimulus were presented for 500 ms. Feedback remained 
on the screen until the next trial was initiated. A 300 ms black fixation cross occurred 
immediately prior to both the stimuli and feedback. Participants were presented with a total of 
480 trials divided into 8 blocks. The task is self-paced, with individuals initiating each trial via 
button press. They begin each block with $1 in the bankroll, and at the end of the task draw a 
number between 1 and 8 and are paid their winnings for that block (averaging $5.50). EEG was 
recorded throughout, as was the time taken to initiate the next trial following presentation of the 
reward/bankroll.  
Feedback Learning. An established feedback learning task was used to assess participants 
approach and avoidance learning tendencies (Frank et al., 2004). The task consists of two phases. 
During the first phase (training), participants are repeatedly presented with three different pairs 
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of stimuli (see Table 1). Each stimulus has a certain probability of resulting in reward, and 
participants have up to 4 seconds per trial to select between them, learning their relative 
contingencies over the duration of the training phase. After each trial, participants are presented 
with feedback regarding whether the stimulus was correct on that particular trial, consisting of 
the word “Correct!” in blue font or “Incorrect!” in red font. Each trial began with a green fixation 
cross presented for a random interval between 250-750 ms. Stimuli were then presented for up 
4000 ms. If no response was made during that window, the phrase “No response detected” was 
presented as feedback. After the selection was made or the 4000 ms expired, a blank screen was 
presented for 350 ms, followed by feedback for 600 ms. A blank screen was presented for 500 
ms between trials. Each of the stimulus pairs occurred 20 times within each of four blocks of 
training. After the fourth block and any subsequent blocks (up to a maximum of 6), participants 
were evaluated to determine if they met a minimum criterion for optimal responding (65% A in 
AB, 60% C in CD, 50% E in EF). Once meeting this criterion or after reaching 6 blocks, 
participants transitioned to the testing phase of the task. During this phase, stimuli are 
recombined so that all 15 possible combinations are presented eight times each across 120 trials. 
No feedback occurs during this phase, but the timing and sequence are otherwise identical to the 
training phase. Participants were paid $0.10 for each correct response during the testing phase in 
order to motivate effort. Approach and avoidance learning are determined by measuring the 
degree to which participants select A (the most-frequently rewarded stimulus overall) vs. avoid B 
(the least-frequently rewarded stimulus) in novel pairings. Novel stimuli were used at each 
session to avoid carryover effects and stimulus assignment to reward probabilities was 
counterbalanced across participants. As with the reward prediction task, EEG was recorded 
throughout the task. 
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Table 1. Sample stimuli for probabilistic learning task 
Name Stimulus  
Reward 
Probability
% 
Name Stimulus  
Reward 
Probability
% 
A  80% B  
20% 
C 
 
70% D 
 
30% 
E 
 
60% F 
 
40% 
 
          Hedonic Capacity. In addition to the above, self-reported anhedonia/hedonic capacity was 
assessed with the Snaith-Hamilton Pleasure Scale  (SHAPS) to determine if the effects are 
captured by self-report. The SHAPS assesses consists of 14 common activities and participants 
rate their capacity to experience pleasure from each of them (Snaith et al., 1995).  
Baseline Measures/Moderators 
Demographic information, including sex, age, race, ethnicity, education, and income 
level, along with a brief medical history were assessed with a series of single item questions. 
Female participants also reported the date their last menstrual cycle began and the anticipated 
start date of their next cycle (this information was updated at each experimental session). The 
Chapman Handedness Inventory (CHI) was used a measure of hand dominance, which is 
believed to influence EEG asymmetry. It consists of 13 items and has high internal consistency 
and test-retest reliability (Chapman & Chapman, 1987). Two measures of nicotine dependence 
were employed in the present study. The Fagerström Test for Nicotine Dependence (FTND) is a 
brief, well-established, unidimensional measure of nicotine dependence (Heatherton, Kozlowski, 
Frecker, & Fagerstrom, 1991). The Wisconsin Inventory of Smoking Dependence Motives 
(WISDM) is a 68-item multidimensional measure that includes 13 subscales (Piper et al., 2004). 
A brief smoking history was obtained, including single item measures to assess age at initiation 
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and duration of smoking, as well as any history of cessation attempts. The Contemplation 
Ladder, an 11-point continuous measure of cessation motivation (Biener & Abrams, 1991), was 
included as part of this history and participants also reported their confidence they would 
succeed if they tried to quit smoking along a 5-point scale (ranging from not at all confident to 
completely confident).  
Several other individual difference measures were obtained as potential moderators of 
experimental effects. These included the Big Five Inventory (BFI), a widely used 44-item 
measure of five dimensions of personality: Extraversion, Neuroticism, Agreeableness, 
Conscientiousness, and Openness (John, Naumann, & Soto, 2008). Analyses for the present 
study focused on only the first two dimensions, which have theoretically tenable links to 
motivational systems. Trait differences in motivational systems were also directly assayed using 
the Behavioral Inhibition System/Behavioral Activation System (BIS/BAS) scale (Carver & 
White, 1994). It includes three subscales for Behavioral Activation System (Reward 
Responsiveness, Drive and Fun-Seeking), with a separate scale for the Behavioral Inhibition 
System. It has adequate reliability, and previous research has documented its relation to other 
measures of approach/avoidance motivation, including those employed in the present study 
(Sutton & Davidson, 1997). The Barratt Impulsiveness Scale – Version 11 (BIS-11) was used to 
assess impulsivity. It consists of 30 items that provide a composite score of multiple dimensions 
(Patton, Stanford, & Barratt, 1995). A cognitive measure was also included; the Cognitive 
Failures Questionnaire (CFQ) is a 25-item self-report measure of commonplace cognitive errors, 
that includes items of memory, distractibility and physical errors (Broadbent, Cooper, 
FitzGerald, & Parkes, 1982).  
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At the end of the baseline session, participants also completed two tasks under the 
supervision of an experimenter. The first was the Reading Span task (Daneman & Carpenter, 
1980), a brief test of working memory. In the task, participants are presented with simple 
sentences of 6-10 words to read aloud and must retain the last word from each sentence while 
reading. After completing a designated number of sentences (ranging from 2 to 5), participants 
are asked to recall as many of the last words as they can. The second was a computerized 
measure of risk-taking, the Balloon Analogue Risk Task (BART; Lejuez et al., 2007). The youth 
version of this task was used due to its relative brevity and ease of determining compensation for 
task performance relative to the version designed for adults. In the task, participants are shown a 
balloon on screen and may earn points displayed in a bank via “pumping” that balloon by 
clicking on a button. However, the balloon increases in size with each pump and has a greater 
risk of popping (no points are awarded if the balloon pops). Thus, each pump results in both 
greater reward and greater risk of losing that reward. Participants must elect to either further 
pump the balloon or collect the points earned for that trial. The number of presses prior to the 
balloon exploding varies randomly across 30 task trials, though increases with each press. 
Compensation for this task was based on the total number of points collected across all trials 
divided amongst four possible categories. These are labeled small, medium, large and bonus and 
corresponded to payments of $1, $3, $5 and $7 respectively. The primary score used to measure 
performance is the average number of pumps on unexploded balloons.   
Smoking Motivation Measures 
Three core constructs thought to play a key role in smoking motivation were measured: 
withdrawal, craving and mood. Withdrawal was measured using the Minnesota Nicotine 
Withdrawal Scale-Revised (MNWS-R), which assesses 15 common symptoms of tobacco 
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withdrawal (Hughes & Hatsukami, 1986, 1998). Craving was measured using the Questionnaire 
on Smoking Urges – Brief (QSU-B), a 10-item measure that includes two separate factors – one 
assessing the desire to smoke for pleasurable effects and one assessing desire to smoke to 
alleviate aversive symptoms (Cox, Tiffany, & Christen, 2001). The Mood Form (MF; Diener & 
Emmons, 1984), which consists of 9 items that span both positive and negative moods, was used 
to assess current mood.            
Cigarette Rating Measures 
Cigarettes were rated using the Modified Cigarette Evaluation Questionnaire (mCEQ; 
Cappelleri et al., 2007). The mCEQ is a 12-item measure of the subjective rewarding effects 
derived from smoking, consisting of 3 subscales (Smoking Satisfaction, Psychological Reward, 
and Aversion) plus 2 single-item measures (Enjoyment of Respiratory Tract Sensations, and 
Craving Reduction).  
Smoking Topography Measures 
          A Clinical Research Support System (CReSS) desktop device was used to measure 
smoking topography. The device allowed for the direct assessment of numerous components of 
smoking behavior, including puffs per cigarette, puff volume, puff duration, inter-puff interval 
and peak flow rate. It is both highly reliable and concordant with other measures of smoking 
topography (Blank, Disharoon, & Eissenberg, 2009).  
Cortical Data Acquisition  
Participants were fitted with a 64-channel electroencephalogram (EEG) cap for 
measurement of resting EEG, and event-related potentials during the computer tasks. The caps 
used (Compumedics; Charlotte, NC) include a standard 10-20 electrode montage, two mastoid 
channels and separate bipolar channels for the monitoring of vertical and horizontal eye 
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movements and blinks. Electrode impedances were kept under 50kΩ. A Neuroscan Synamps2 
system was used for signal amplification. Data was recorded in AC mode at 1000 Hz with an 
online bandpass filter of .05-200 Hz. A vertex reference was used during acquisition, but re-
referenced to the average of the two mastoid electrodes offline.  
Data Processing 
Smoking Topography. Puff data was processed separately for each cigarette using the 
Puff CleanUp Utility (Borgwaldt, Inc.; Hamburg, Germany). A puff was collapsed into the 
preceding puff if the inter-puff interval was less than 300 ms. Puffs with volumes below 5.0 ml 
or durations below 200 ms were removed. Indices were then averaged across puffs, with the 
exception of number of puffs and total puff volume (which was a sum of individual puff volumes 
for a given cigarette).  
Cortical Data. All data was visually inspected for paroxysmal artifact and problematic 
sections were flagged for removal.  Data processing was done using a set of custom Matlab 
scripts and existing toolboxes (details as follows). Bad channels were replaced using a spherical 
spline interpolation procedure (Srinivasan, Nunez, Tucker, Silberstein, & Cadusch, 1996) and 
channels with non-standard locations (i.e. CB1, CB2) were removed from the dataset. Data was 
down-sampled to 500 Hz and an optimal finite impulse response filter was generated (Cook & 
Miller, 1992) for the application of lowpass filters (Resting EEG: 50 Hz; Task-Based EEG: 30 
Hz) to the continuous data. Resting EEG was then divided into 2000ms epochs with 1500 ms 
overlaps. Task-Based EEG was epoched from 200 ms prior to the relevant event to 1000 ms 
following it. Both resting and task data were then subjected to (separate) Independent 
Components Analyses (ICAs; Jung et al., 1998) to identify and parse eye movements, eyeblinks 
and other artifacts using runica within the EEGlab toolbox (Delorme & Makeig, 2004). 
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Artifactual components were identified using the ADJUST plugin (Mognon, Jovicich, Bruzzone, 
& Buiatti, 2011) and removed, with the remaining components being back-projected to the scalp. 
Residual artifacts were then identified according to criteria set forth by Foti et al. (2009) and 
offending epochs were flagged for removal. All channels were then re-referenced to the average 
of the two mastoid electrodes. 
Frontal asymmetry of resting EEG was calculated according to standard procedures 
(Coan & Allen, 2004). A fast Fourier Transformation (FFT) using a Hamming window was 
conducted on each epoch. Power in the alpha frequency band (8-13 Hz) was then extracted, 
averaged across epochs and log transformed. Difference scores were computed for frontal 
electrodes (i.e. F2-F1; F4-F3; F6-F5; F8-F7). It was these scores that were targeted for analysis. 
For event-related potentials, epochs time-locked to the stimulus of interest (S2 on reward 
prediction task, feedback on probabilistic learning task) were extracted. Epochs were all baseline 
corrected to the 200 ms pre-stimulus interval. Signals within the time window of interest were 
then averaged across epochs and electrodes based on regions of interest identified in prior 
research using each task (Frank et al., 2005; Martin, Potts, Burton, & Montague, 2009) and 
visual inspection of the waveforms. In the case of the MFN on the reward prediction task, this 
corresponded to the signal from electrodes FP1, FPz, FP2, AF3, AF4, F1, Fz, F2, FC1, FCz and 
FC2 occurring 250-350 ms following S2 onset. The same set of electrodes was used for 
extraction of the FRN on the probabilistic learning task with the exception of FP1, FPz and FP2, 
which exhibited minimal variance as a function of trial type and were thus excluded. Signals 
were extracted from these electrodes from the 220-320 ms window following feedback onset.  
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Data Analysis 
Except where otherwise noted, all analyses employed a mixed model framework with a 
random intercept for subject. A restricted maximum likelihood approach was used for variance 
component estimation. An initial model was run for each outcome with only relevant 
experimental variables entered to determine overall effects. Moderator variables were grand-
mean centered before being separately introduced into the model to determine their overall 
influence and potential interaction with all possible combination of experimental effects. A 
comparable approach was used for testing the concordance of primary outcomes with smoking 
motivation variables. The most temporally proximal value was used for each comparison (i.e. the 
third craving assessment for the first resting EEG, the fourth craving assessment for the second 
resting EEG, the third craving assessment for the reward prediction on sessions where it was 
administered first, etc.). Owing to the large number of moderators and smoking motivation 
variables examined, the Benjamini-Hochberg approach was used to control the false discovery 
rate (FDR; Benjamini & Hochberg, 1995) for each series of analyses. 
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Results 
Sample Characteristics 
 A total of 41 participants completed the baseline session and both experimental sessions. 
An additional 7 participants completed the baseline session and one experimental session.  
Demographic and smoking characteristics of the sample are presented in Table 2. The 
prototypical participant was a relatively heavy smoker with a moderate level of nicotine 
dependence, in their mid-late 30’s and with relatively low educational attainment. Completers 
and non-completers did not differ on any of these variables (all p’s > .05).  
Table 2. Sample Characteristics 
 Completers Only All Participants 
 Mean (SD) or % Mean (SD) or % 
Demographic Variables   
     Age 38.2 (10.4) 37.9 (9.8) 
     Sex (% female)   36.6% 35.4% 
     Race (% non-white) 26.8% 29.2% 
     Ethnicity (% Hispanic) 12.2% 12.5% 
     Education Level (% ≤ HS Degree) 51.2% 54.2% 
     Handedness (% Right-handed) 68.3% 68.8% 
Smoking Variables   
     Cigarettes Per Day 20.4 (10.7) 20.3 (10.3) 
     FTND 4.9 (1.9) 5.1 (1.9) 
     Contemplation Ladder 4.4 (2.7) 4.5 (2.5) 
     Baseline CO Level 32.4 (15.9) 31.9 (15.0) 
     Age Became Regular Smoker 17.9 (4.3) 18.0 (4.6) 
     # Past Quit Attempts 1.6 (2.4) 1.6 (2.3) 
     Preferred Cigarette Type (% Menthol) 41.5% 43.8% 
Note. HS = High School; FTND = Fagerstrӧm Test for Nicotine Dependence;  
CO = Carbon Monoxide. Owing to the small number of left-handed individuals 
 (< 5%), this category was collapsed with ambidextrous for analysis. 
Exposure Biomarkers 
 The expected decrease in CO level from baseline to experimental sessions was observed, 
F (1, 89.0) = 387.28, p < .001. This decrease did not differ as a function of nicotine contents, F 
(1, 96.2) = 0.56, p = .457. Initial CO levels at experimental sessions also did not differ as a 
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function of nicotine contents, F (1, 41.8) = 1.59, p = .214. At experimental sessions, a significant 
main effect of cigarette number was observed, indicating that the CO boost increased across the 
cigarettes, F (2, 212.7) = 3.46, p = .033. Post-hoc testing revealed a trend-level increase in the 
size of the CO boost from the first to the second cigarette (p = .064) and a significant increase 
from the first to the third cigarette (p = .012).  A significant main effect of withdrawal status 
indicated that CO boosts were larger overall for sessions with nicotine cigarettes, F (1, 220.2) = 
5.77, p = .017. However, the interaction between withdrawal status and cigarette number was not 
significant, F (2, 212.7) = 1.25, p = .290. Means and standard deviations for all CO levels are 
presented in Table 3.  
Table 3. Carbon monoxide level means and standard deviations 
Status Baseline Experimental 
 CO Pre-Cig 1 Post-Cig 1 Pre-Cig 2 Post-Cig 2 Pre-Cig 3 Post-Cig 3 
 M (SD) M (SD M (SD) M (SD) M (SD) M (SD) M (SD) 
Placebo 31.9 (15.0) 9.8 (6.0) 15.3 (7.2) 13.0 (6.2) 19.3 (7.5) 16.5 (6.6) 22.7 (7.7) Nicotine 10.7 (6.6) 16.8 (7.8) 13.9 (6.9) 20.3 (8.2) 16.9 (7.0) 24.0 (8.9) 
Note. CO = Carbon Monoxide. 
Smoking Motivation 
 There was no evidence to suggest there were differences in the initial (pre-smoking) 
scores for craving [F (1, 41.2) = 0.42, p = .519] or negative mood [F (1, 41.8) = 2.41, p = .128] 
as a function of the nicotine content of the sessions. There were weak trend-level effects 
indicating participants reported slightly higher levels of both withdrawal [F (1, 42.4 = 2.96, p = 
.093] and positive mood [F (1, 41.4) = 3.03, p = .089] at nicotine sessions prior to smoking. In an 
abundance of caution, pre-smoking scores for all available variables were included as covariates 
in the subsequent analyses examining scores on these measures administered after each bout of 
smoking. Table 4 depicts the mean values for each internal state across time points separately as 
a function of session type (i.e. nicotine contents). 
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 Craving. After adjusting for baseline craving, results revealed a significant main effect of 
nicotine on QSUB total scores, F (1, 215) = 8.65, p = .004, with participants in placebo sessions 
reporting higher craving across time points. A significant main effect for cigarette number was 
also observed, F (2, 210.3) = 12.59, p < .001. Post-hoc testing revealed craving was 
significantly higher following the first cigarette, relative to the second (p = .002) and third (p < 
.001) cigarettes, with only a small trend-level differences between the second and third cigarettes 
(p = .085). The interaction between nicotine and cigarette number was not significant, F (2, 
210.3) = 0.46, p = .955. 
Table 4. Internal state means and standard deviations 
Variable Range Session Baseline Post-Cig 1 Post-Cig 2 Post-Cig 3 
   M (SD M (SD) M (SD) M (SD) 
Craving 10-70 Placebo Nicotine 
40.20 (14.37) 23.09 (11.99) 20.13 (12.14) 18.40 (10.90) 
42.03 (16.90) 21.02 (12.75) 18.23 (11.14) 16.86 (11.07) 
Withdrawal 0-32 Placebo Nicotine 
8.11 (5.35) 3.67 (3.38) 2.47 (2.53) 2.76 (2.63) 
9.39 (5.72) 3.18 (3.19) 2.37 (2.92) 2.34 (2.59) 
Positive Mood 0-6 Placebo Nicotine 
2.54 (1.50) 2.76 (1.51) 2.79 (1.61) 2.74 (1.53) 
2.69 (1.57) 3.19 (1.46) 3.05 (1.50) 2.97 (1.57) 
Negative Mood 0-6 Placebo Nicotine 
0.75 (1.03) 0.37 (0.68) 0.23 (0.47) 0.25 (0.47) 
0.96 (1.34) 0.27 (0.46) 0.17 (0.39) 0.22 (0.50) 
Note. Range depicts the full range of possible scores for the scale. Craving and withdrawal use summed scores, 
 mood measure uses mean scores.  
 Withdrawal. Although participants reported greater withdrawal across time points in the 
placebo session, this effect did not reach significance, F (1, 224.6) = 3.38, p = .067. A significant 
effect of cigarette number was observed, F (2, 209.7) = 7.77, p = .001. Post-hoc tests revealed 
significant differences from the first to the second (p = .000) and third (p = .002) third cigarettes, 
with no differences between the second and third cigarettes (p = .637). As with craving, the 
nicotine x cigarette number interaction was not significant, F (1, 209.7) = 0.27, p .762.  
 Positive Mood. Participants reported higher levels of positive mood across time points 
during the nicotine session, F (1, 223.5) = 8.86, p = .003. The effect of cigarette number was not 
significant, F (2, 205.7) = 0.95, p = .388, nor was the nicotine x cigarette number interaction, F 
24 
(2, 205.7) = 0.72, p = .487. 
 Negative Mood. Participants reported lower levels of negative mood across time points 
during the nicotine sessions, F (1, 220.1) = 6.02, p = .015. A significant effect of cigarette 
number was also found, F (2, 209.6) = 5.33, p = .006. Consistent with prior results, post-hoc tests 
indicated this was driven by significant differences between the first and the second (p = .002) 
and third (p = .025) cigarettes, with no difference between the second and third cigarettes (p = 
.367). The nicotine x cigarette number interaction was not significant, F (2, 209.6) = 0.56, p = 
.572.   
Cigarette Ratings 
 Means and standard deviations of each mCEQ subscale as a function of nicotine contents 
(i.e. withdrawal status) are presented below in Table 5. 
Table 5. Cigarette rating scale means and standard deviations 
Variable Range Session Cig 1 Cig 2 Cig 3 
   M (SD) M (SD) M (SD) 
Smoking Satisfaction 1-7 Placebo Nicotine 
3.81 (1.41) 3.61 (1.52) 3.49 (1.45) 
4.65 (1.41) 4.11 (1.65) 3.98 (1.68) 
Psychological Reward 1-7 Placebo Nicotine 
2.79 (1.39) 2.32 (1.25) 2.33 (1.27) 
3.36 (1.49) 2.67 (1.48) 2.64 (1.40) 
Craving Reduction 1-7 Placebo Nicotine 
4.11 (2.00) 3.82 (1.89) 3.96 (1.87) 
4.93 (1.76) 4.16 (2.08) 3.64 (1.98) 
Enjoyment of 
Respiratory Sensations 1-7 
Placebo 
Nicotine 
2.93 (1.66) 2.80 (1.75) 2.62 (1.57) 
3.91 (1.84) 3.43 (1.90) 3.25 (1.94) 
Aversion 1-7 Placebo Nicotine 
1.70 (0.89) 1.38 (0.61) 1.26 (0.59) 
2.16 (1.04) 1.52 (0.75) 1.50 (0.69) 
Note. Range depicts the full range of possible scores for the subscale.  
 Smoking Satisfaction. A significant main effect of nicotine on satisfaction derived from 
smoking was found, F (1, 218.0) = 27.34, p < .001, with nicotine cigarettes being rated as more 
satisfying overall. A significant main effect of cigarette number was also present, F (2, 214.3) = 
9.53, p < .001. Post-hoc tests revealed a pattern of findings similar to what was observed for  
internal state indices, with ratings of the first cigarette significantly higher than both the second 
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(p = .002) and third (p < .001) cigarettes, but no difference between the second and third 
cigarettes (p = .293). The nicotine x cigarette number interaction was not significant, F (2, 214.3) 
= 1.42, p = .243.  
 Psychological Reward. Nicotine also had a significant effect on the psychological reward 
derived from smoking, F (1, 217.60) = 13.66, p < .001, with nicotine cigarettes being rated as 
more rewarding overall. As above, a significant main effect of cigarette number was also 
observed, F (2, 214.0) = 20.37, p < .001. Post-hoc tests again indicated differences between both 
the first and the second cigarette (p < .001), as well as the first and the third cigarette (p < .001), 
with no difference between the second and third cigarette (p = .897). The nicotine x cigarette 
number interaction was not significant, F (2, 214.0) = 0.93, p = .398.   
 Craving Reduction. A trend-level finding indicated nicotine cigarettes were rated as being 
slightly more effective for reducing craving, F (1, 220.5) = 3.27, p = .072. A significant main 
effect of cigarette number was observed, F (2, 214.3) = 8.17, p < .001. Post-hoc tests indicated 
the presence of significant differences in ratings of craving reduction between the first and both 
the second (p = .005) and third (p < .001) cigarettes, with no difference between the second and 
third cigarettes (p = .296). However, all of these findings were qualified by a significant nicotine 
x cigarette number interaction, F 2, 214.3) = 4.74, p = .010. When broken down, this interaction 
indicated that only the first cigarette was rated as more effective for reducing craving based on 
its nicotine content (p = .006), with no statistically significant differences for the second (p = 
.227) or third (p = .161) cigarettes.   
 Respiratory Sensation Enjoyment. Nicotine cigarettes were rated as producing 
significantly more enjoyable respiratory tract sensations, F (1, 217.9) = 26.59, p < .001. A 
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significant effect of cigarette number was also observed, F (2, 214.1) = 6.28, p = .002. Post-hoc 
testing revealed that ratings of the first cigarette differed from both the second (p = .028) and 
third (p = .001) cigarettes, but that ratings of the second and third cigarette were comparable (p = 
.195). The nicotine x cigarette number interaction was not significant, F 2, 214.1) = 1.04, p = 
.355. 
 Aversion. Nicotine cigarettes were also rated as producing significantly more aversive 
sensations overall, F (1, 220.8) = 21.31, p < .001. As with other indices, a significant main effect 
of cigarette number was observed, F (2, 212.7) = 25.59, p < .001. As above, post-hoc tests 
revealed indicated the first cigarette was rated as significantly more aversive than the second (p < 
.001) or the third (p < .001) cigarettes, but the second and third cigarettes did not differ from one 
another (p = .388). The nicotine x cigarette number interaction was not significant, F (2, 212.7) = 
1.83, p = .162.   
Smoking Topography 
 Due to technical problems, topography data was unavailable for the first cigarette of a 
placebo session for one participant, the first cigarette of a nicotine session for one participant and 
for the third cigarette of a placebo session for one participant. Additionally, all topography 
indices were screened for values outlying from the grand mean and values more than 3 SDs from 
the mean were excluded from analyses. This resulted in the exclusion of additional values for: 
Average Interpuff Interval (1 value), Average Puff Duration (2 values), Average Puff Volume (1 
value) and Total Puff Volume (6 values). Values were also screened for their deviation from 
subject-specific means, but no additional outlying values were identified. Means and standard 
deviations of topography indices are presented in Table 6.  
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Table 6. Smoking topography means and standard deviations 
Variable Session Cig 1 Cig 2 Cig 3 
  M (SD) M (SD) M (SD) 
Total Puff 
Volume 
Placebo 
Nicotine 
1163.12 (399.95) 1051.00 (286.63) 1135.42 (379.97) 
1114.55 (331.45) 1035.77 (267.16) 1017.31 (284.10) 
Average Puff 
Volume 
Placebo 
Nicotine 
98.61 (29.93) 96.66 (32.37) 93.33 (27.91) 
92.54 (32.06) 87.78 (26.77) 85.28 (28.36) 
Average Flow 
Rate 
Placebo 
Nicotine 
58.67 (15.92) 56.11 (14.93) 56.52 (16.65) 
59.05 (16.73) 55.79 (15.39) 53.18 (13.78) 
Average Inter-
Puff Interval 
Placebo 
Nicotine 
14.70 (5.56) 15.21 (5.83) 14.10 (5.06) 
16.28 (6.16) 16.18 (5.54) 14.85 (5.58) 
Average Puff 
Duration 
Placebo 
Nicotine 
2.14 (0.62) 2.21 (0.61) 2.20 (0.72) 
2.00 (0.65) 2.05 (0.70) 1.98 (0.63) 
Number of 
Puffs 
Placebo 12.68 (3.37) 11.89 (2.90) 12.70 (3.10) 
Nicotine 12.58 (3.11) 12.36 (3.26) 12.55 (3.27) 
Note. Puff volume is in milliliters. Flow rate is in milliliters per second. Inter-puff interval is in seconds.  
Puff duration is in seconds. 
 Total Puff Volume. Results revealed a weak trend-level main effect of nicotine content on 
total puff volume, F (1,216.5) = 3.07, p = .081, indicating higher total puff volume across 
cigarettes during placebo sessions. A similarly weak trend-level finding was observed for 
cigarette number [F (2, 206.9) = 2.51 p = .083]. Post-hoc tests revealed a trend suggesting 
significantly higher puff volume for the first cigarette relative to the third (p = .055), with no 
differences between the first and second cigarette (p = .300) nor the second and third cigarettes 
(p = .366). The cigarette number x nicotine content interaction was not significant [F (2, 209.1) = 
0.16, p = .851.  
 Average Puff Volume. Results revealed a significant main effect of nicotine content on 
average puff volume, F (1,214.2) = 7.00, p = .009, indicating that participants’ puff volume was 
significantly higher for placebo cigarettes. No main effect of cigarette number was observed [F 
(2, 209.1) = 1.87, p = .157], nor was there a significant interaction between cigarette number and 
nicotine contents [F (2, 209.1) = 0.16, p = .851.  
 Average Peak Flow Rate. There was a significant effect of cigarette number for average 
flow rate [F (2, 211.3) = 4.26, p = .015] indicating higher flow rates for the first relative to the 
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second (p = .037) and third (p = .005) cigarettes, with no difference between the second and third 
cigarettes (p = .473). There was no main effect of nicotine content [F (1, 216.1) = 0.09, p = .765] 
nor was there evidence of a nicotine contents x cigarette number interaction [F (2, 211.3) = 1.19, 
p = .307].  
 Average Inter-puff Interval. A significant main effect of nicotine content was found for 
inter-puff interval [F (1, 212.8) = 15.22, p < .001] indicating inter-puff intervals were shorter for 
placebo cigarettes than nicotine cigarettes. A significant main effect of cigarette number was also 
found [F (2, 209.8) = 6.940, p = .002]. Post-hoc tests revealed this was driven by a significantly 
shorter inter-puff interval at the third cigarette relative to the first (p = .006) and second (p = 
.001) cigarettes, with no difference between the first and second cigarettes (p = .592). The 
nicotine content x cigarette number interaction was not significant [F (2, 209.8) = 0.63, p = 
.532].  
 Average Puff Duration. A main effect of nicotine content [F (1, 211.0) = 17.32, p < .001] 
indicated participants took significantly longer puffs on placebo relative to nicotine cigarettes. 
There was no effect of cigarette number [F (2, 208.7) = 0.76, p = .471], nor was there a nicotine 
contents x cigarette number interaction [F (2, 208.7) = 0.01, p = .992]. 
 Number of Puffs. A trend-level finding suggested number of puffs taken differed across 
cigarettes [F (2, 211.0) = 2.71, p = .069], with post-hoc testing suggesting slightly fewer puffs 
being taken on the second cigarette relative to both the first (p = .048) and third (p = .043) 
cigarette, with no difference between the first and third cigarette (p = .968). No effect of nicotine 
content was observed [F (1, 214.7) = 0.21, p = .646], nor was there evidence of a nicotine 
content x cigarette number interaction [F (2, 211.0) 1.01, p = .367]. 
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Hedonic Capacity 
 Anhedonia scores ranged from 14-56. Participants did report greater capacity to 
experience pleasure in the nicotine condition (MPlacebo = 44.56, SDPlacebo = 5.61; MNicotine = 46.11, 
SDNicotine = 7.15), but this effect did not reach statistical significance, F (1, 43.0) = 3.00, p = .090. 
Motivational State 
 Frontal Asymmetry. Results revealed a significant main effect of nicotine content [F (1, 
670.85) = 11.20, p < .001] with significantly lower scores during placebo sessions than nicotine 
sessions (indicative of greater left hemisphere alpha). Neither session order, nor recording 
instance within session were associated with asymmetry scores and did not interact with the 
nicotine effect (all p’s > .05). A significant main effect for electrode sites was found [F (1, 
653.252) = 4.90, p = .002], indicating overall asymmetry scores differed across the homologous 
electrode pairs. However, this finding did not interact with nicotine content [F (3, 653.25) = 
0.21, p = .889]. When broken down across specific electrode pairs, results indicated the nicotine 
effect was significant for F1-F2 [F (1, 134.93) = 4.52, p = .035] and the F3-F4 pair [F (1, 
133.44) = 7.86, p = .006]. Although similar in size and direction, effects did not reach 
significance for either the F5-F6 pair [F (1, 133.68) = 2.26, p = .136] or the F7-F8 pair [F (1, 
134.31) = 2.88, p = .092]. Results are presented in Figure 1.  
 Moderators. For all moderator analyses, a main effect of electrode site was retained as a 
covariate. The relevant moderator variable was then introduced to determine its association with 
overall asymmetry scores and whether it interacted with nicotine. All moderators were tested 
individually in separate models. Results are presented in Table 7. Examination of these 
moderator effects indicated the above effects of frontal asymmetry were present in men (p < 
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.001), but not women (p = .506). The effect was present among those who had not made a quit 
attempt in the past (p < .001) but not among those who had tried to quit previously (p = .631). 
Individuals with greater motivation to quit exhibited smaller withdrawal-induced shifts towards 
left frontal alpha asymmetry (B = 0.00426, 95% CI [0.00173, 0.00678], p < .001). Individuals 
who were menthol smokers (p < .001) exhibited larger effects than those who were non-menthol 
smokers (p = .364). Lastly, participants with relatively greater activation system scores (i.e. 
approach-driven motivational tendencies) exhibited larger shifts towards left frontal alpha 
asymmetry. This finding converged across the Reward Response (B = -0.0256, 95% CI [-0.0362, 
-0.0150], p < .001), Drive (B = -0.0193, 95% CI [- 0.0302, - 0.0083], p < .001) and Fun-Seeking 
subscales (B = -0.0243, 95% CI [-0.0366, -0.0119], p < .001) of the BIS/BAS measure.  
 Association with Smoking Motivation. Results are presented in Table 8. As above, 
electrode site was retained as a covariate for all analyses. Following the FDR correction 
procedure, five indices of smoking motivation retained a significant overall association with 
frontal asymmetry (i.e. craving, negative mood, craving reduction in response to the cigarette, 
average puff volume and average inter-puff interval). No interactions with nicotine content were 
observed after correction, thus these associations do not appear to be strictly dependent on 
withdrawal state. Greater craving was associated with lower asymmetry difference scores (B = -
0.00080, 95% CI [-0.00135, -0.00026], p = .004) and relatedly greater reductions in craving 
following smoking were associated with higher asymmetry difference scores (B = 0.00495, 95% 
CI [0.00193, 0.00798], p = .001). Greater negative mood was associated with higher asymmetry 
difference scores (B = 0.02118, 95% CI [0.00584, 0.03651], p = .007). Greater puff volume was 
associated with lower asymmetry scores (B = -0.00031, 95% CI [-0.00051, -0.00010], p = .004) 
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and longer inter-puff intervals were associated with higher asymmetry scores (B = 0.00186, 95% 
CI [0.00070, 0.00301], p = .002). 
Reward Sensitivity 
 Behavioral. Trials with response times < 100 ms or > ± 3 SDs from the grand mean or the 
individual’s trial-type mean for a given session were removed (7.5% of trials). To account for 
this missing data, mixed models examining response times were analyzed directly at the trial 
level rather than averaging them together prior to analysis. One nicotine session and one placebo 
session were outliers with regards to the number of trials eliminated due to the response time 
cleaning procedures, so were excluded from all response time analyses presented below. Among 
the remaining sessions, a significant nicotine content x prediction x reward interaction was 
observed [F (1, 38565.99) = 8.70, p = .003]. When broken down, this interaction indicated the 
presence of slowed response times to both unpredicted rewards (p < .001) and unpredicted non-
rewards (p < .001) relative to their predicted counterparts during placebo sessions. In contrast, 
during nicotine sessions slowed response times were observed in response to unpredicted 
rewards relative to predicted rewards (p < .001), but not unpredicted non-rewards relative to 
predicted non-rewards (p = .355). These findings are displayed in Figure 2. 
 Neural. Visual inspection of the waveforms confirmed the presence of a robust MFN 
peaking 285 ms after onset of the S2 stimulus, with the largest variability observed at the Fz 
electrode. Results confirmed the presence of the anticipated prediction x reward interaction [F 
(1, 299.80) = 31.74, p < .001], indicating prediction errors resulted in a more positive deflection 
for reward trials and a more negative deflection for non-reward trials. A significant main effect 
of nicotine contents was found [F (1, 303.72) = 13.12, p < .001], revealing that the MFN was 
more negative during placebo sessions. However, nicotine contents did not interact with 
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prediction or reward trial types, nor was the hypothesized nicotine contents x reward x prediction 
interaction significant (all p’s > .170).  Findings are displayed in Figure 3 and waveform at 
electrode Fz is presented in Figure 4.  
 Moderators. Results of moderator analyses for behavior are presented in Table 9. These 
indicated that heavier smokers (i.e. higher CPD) had larger increases in response time in 
response to unpredicted trials relative to predicted trials (B = 2.39, 95% CI [1.30, 3.49], p < 
.001). Individuals who did not initiate smoking until they were older (B = 3.29, 95% CI [-5.20, 
1.38], p = .001) or who were high in behavioral inhibition (B = -39.24, 95% CI [, -57.73, -20.76], 
p < .001) had smaller increases in response time in response to reward trials relative to non-
reward trials. With regards to the effects of nicotine on response to reward trials, a significant 
Sex x Nicotine x Reward interaction was observed (B = 48.84, 95% CI [11.47, 86.21], p = .010). 
Breaking down this effect indicated it was driven by trend-level findings in opposite directions, 
suggesting nicotine had opposing effects in men and women. Men exhibited longer response 
times to rewards relative to non-rewards when receiving nicotine (p = .069), whereas women 
exhibited shorter response times to rewards relative to non-rewards when receiving nicotine. An 
Ethnicity x Nicotine x Reward interaction was also observed (B = -116.63, 95% CI [-171.44, -
61.83], p < .001). This interaction indicated that nicotine had minimal effect on response to 
rewards among individuals not of Hispanic ethnicity (p = .304), but individuals of Hispanic 
ethnicity had faster response times to reward relative to non-reward trials during placebo 
sessions (p < .001), but slower response times to reward relative to non-reward trials during 
nicotine sessions (p = .013).  A significant Nicotine Dependence (WISDM) x Nicotine x Reward 
interaction (B = -2.61, 95% CI [-3.90, -1.31], p < .001) indicated that withdrawal slowed 
response times on reward trials the most for highly dependent individuals. A Neuroticism x 
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Nicotine x Reward interaction (B = -39.89, 95% CI [-66.83, -12.95], p = .004), with response 
times to rewards being slowest for individuals with high levels of neuroticism. In contrast, a 
significant Extraversion x Drug x Reward interaction (B = 46.65, 95% CI [20.71, 72.60], p < 
.001) indicated that higher extraversion was relatively protective of withdrawal-induced reward-
processing deficits. Lastly, a Behavioral Inhibition x Drug x Reward (B = 82.39, 95% CI [45.43, 
119.34], p < .001) indicated those low in behavioral inhibition exhibited a robust increase in 
response time to reward trials during placebo sessions, whereas those high in behavioral 
inhibition had faster responses to rewards during placebo sessions.  
 No moderators of MFN amplitude on the reward prediction task remained significant 
following FDR correction (see Table 10).  
 Association with Smoking Motivation. Results for smoking motivation and response time 
are presented in Table 11. A number of moderators exhibited moderate to strong positive 
(craving, withdrawal, positive mood, cigarette satisfaction, cigarette psychological reward, 
cigarette respiratory tract sensations, CO boost, total puff volume, average puff volume, average 
flow rate, average puff duration) or negative (cigarette craving reduction, cigarette aversive 
effects, number of total puffs) relationships with response time. A Psychological Reward x 
Prediction interaction indicated those with higher levels of psychological reward from the most 
proximal cigarette had reduced response times to unpredicted trials (B = -14.38, 95% CI [-22.75, 
-6.01], p < .001). A significant Negative Mood x Reward interaction (B = 33.16, 95% CI [15.12, 
51.21], p < .001) indicated those with a more negative mood had slowed response times on 
reward trials. A CO Boost x Reward interaction (B = 5.20, 95% CI [2.27, 8.12], p < .001) 
suggested those with a larger CO boost from the most proximal cigarette also had slowed 
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response times on reward trials.  
 With regards to nicotine, a number of motivational variables were associated with the 
effect of nicotine on both prediction and reward trial response times. The increase in response 
time on unpredicted trials was significantly greater during placebo sessions amongst those 
reporting higher levels of negative mood, as evidenced by a Negative Mood x Nicotine x 
Prediction Type interaction (B = -67.25, 95% CI [-112.12, -22.38], p = .003). This increase was 
also observed among those with low inter-puff intervals, as evidenced by an Inter-puff Interval x 
Nicotine x Prediction Type interaction (B = 5.56, 95% CI [1.60, 9.52], p = .006). A significant 
Craving x Nicotine x Reward Type interaction (B = -3.06, 95% CI [-4.69, -1.42], p < .001) 
indicated a strong positive relationship between craving and response time following reward 
trials during placebo sessions. Comparable interaction effects were observed for nicotine 
withdrawal (B = -10.71, 95% CI [-17.40, -4.04], p = .002), negative mood (B = -63.18, 95% CI [-
99.27, -27.08], p = .001), smoking satisfaction (B = -24.06, 95% CI [-35.27, -12.85], p < .001), 
psychological reward from smoking (B = -18.12, 95% CI [-31.66, -4.58], p = .009), reduction in 
craving from smoking (B = -16.38, 95% CI [-25.40, -7.36], p < .001). However, an opposing 
effect was found for enjoyment of respiratory tract sensations from smoking (B = -13.62, 95% CI 
[-23.88, -3.36], p = .009), which indicated a weaker relationship between this variable and 
response time following reward trials during placebo sessions. Lastly, a significant four-way 
Positive Mood x Nicotine x Prediction x Reward interaction was found (B = 57.96, 95% CI 
[28.63, 87.28], p < .001), indicating positive mood was most strongly associated with response 
time for unpredicted rewards during placebo sessions. 
 Results of analyses examining associations between MFN amplitude and smoking 
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motivation variables are presented in Table 12. As shown, several variables were associated with 
MFN amplitude across all trial types (i.e. moderator main effects). MFN amplitude was 
positively associated with positive mood (B = 0.45, 95% CI [0.09, 0.81], p = .015), satisfaction 
from smoking (B = 0.37, 95% CI [0.07, 0.68], p = .016), psychological reward from smoking (B 
= 0.62, 95% CI [0.27, 0.98], p = .001), boost in carbon monoxide level (B = 0.17, 95% CI [0.06, 
0.29], p = .003) and inter-puff interval (B = 0.10, 95% CI [0.02, 0.18], p = .010). In contrast, a 
negative association was observed between MFN amplitude and total puff volume (B = -0.001, 
95% CI [-0.002, -0.001], p = .002). However, there were no significant interactions between any 
of the smoking motivation variables and either nicotine contents or the trial conditions (i.e. 
reward, prediction). 
Feedback Learning 
 Behavioral. For 11 placebo sessions and 10 nicotine sessions, participants did not choose 
stimulus A over B during the testing phase on at least 50% of trials. To maintain consistency 
with prior research these sessions are excluded from the analyses presented below, though it 
should be noted that the pattern of findings for primary outcomes did not differ substantially 
when analyses were repeated with all sessions included. Limited variability precluded estimation 
of random effects for numerous analyses conducted on this task, so population-averaged models 
with a compound symmetry covariance matrix (analogous to repeated measures ANOVA) were 
employed throughout. There was no effect of trial type [F (1, 97.29) = 0.35, p = .555], nicotine 
content [F (1, 124.47) = 0.06, p = .807], nor was there evidence of a nicotine content x trial type 
interaction [F (1, 97.29) = 0.68, p = .411]. Separate analyses confirmed that nicotine content did 
not impact either Choose A (p = .186) or Avoid B (p = .565) performance. Results are presented 
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in Figure 5.  
 Neural. Visual inspection of the topographic plots revealed the presence of a robust FRN 
in the form of a negative-going wave peaking 300 ms after the onset of feedback. As with the 
MFN, maximum variability and the strongest trial type effects were observed at the Fz electrode. 
Results confirmed the presence of a robust effect of feedback type [F (1, 126.08) = 28.45, p = 
.003], with incorrect feedback producing a more negative FRN than correct feedback. Similar to 
results on the reward prediction task, a significant main effect of nicotine content emerged [F 
(1,129.9) = 9.20, p = .003) indicating that independent of trial type, waveforms were more 
negative during placebo sessions relative to nicotine sessions. However, there was no evidence 
of a nicotine content x feedback type interaction [F (1, 126.08) = 0.20, p = .659].  These effects 
are illustrated in Figure 6. The waveform at the Fz electrode is depicted in Figure 7. 
 Moderators. Results of moderator analyses for accuracy on the testing phase of the task 
are presented in Table 13. Moderator analyses of FRN amplitude during the training phase are 
presented in Table 14. No moderators remained significant following FDR correction.  
 Association with Smoking Motivation. Only one effect for probabilistic learning accuracy 
remained significant following FDR correction, a Withdrawal x Nicotine Content x Learning 
Type interaction (B = -0.11, 95% CI [-0.18, -0.04], p = .002). This effect indicated the presence 
of a positive relationship between Avoid B performance and withdrawal symptoms during 
placebo sessions, but a negative association during nicotine sessions.  A significant negative 
relationship was observed between average peak flow rate and FRN amplitude (B = -0.08, 95% 
CI [-0.14, -0.03], p = .001). No other effects reached significance after FDR correction. 
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Figure 1. Effects of nicotine on frontal alpha asymmetry  
Note. Bars represent standard error of the mean. * p < .05; ** p < .01  
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Figure 2. Mean response times on reward prediction task 
Note. Bars represent standard error of the mean. *** p < .001 
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Figure 3. Mean MFN amplitude on reward prediction task 
Note. Bars represent standard error of the mean 
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Figure 4. Neural response to S2 stimuli on reward prediction task at Fz electrode. 
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Figure 5. Testing outcomes on probabilistic learning task 
Note. Bars represent standard error of the mean.  
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Figure 6. Mean FRN amplitude during training phase of probabilistic learning  
 
Note. Bars represent standard error of the mean. *** p < .001 
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Figure 7. Neural responses to feedback on probabilistic learning task at Fz electrode. 
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Table 7. Moderators of frontal asymmetry 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Effects that remain significant following FDR correction (done separately by  
column) are bolded. FTND = Fagerström Test for Nicotine Dependence; WISDM =  
Wisconsin Inventory of Smoking Dependence Motives; BART = Balloon Analogue  
Risk Task; BISBAS = Behavioral Inhibition Systems/Behavioral Activation Systems;  
CFQ = Cognitive Failures Questionnaire; RS = Reading Span 
  
 Main Effect Interaction 
 F P-value F P-value 
Demographic     
     Sex 0.01 .942 11.29 < .001 
     Race 0.53 .469 0.15 .698 
     Ethnicity 3.64 .063 1.62 .203 
     Education Level 0.87 .355 0.00 .962 
     Age 3.08 .086 0.06 .803 
     Handedness 0.24 .627 1.99 .159 
Smoking     
     Cigarettes per day 0.07 .795 0.08 .779 
     Age at first cigarette 0.07 .791 1.22 .271 
     Motivation to quit 0.04 .848 11.15 < .001 
     Menthol smoker 0.18 .670 7.00 .008 
     Quit History 0.02 .897 17.55 < .001 
     Quit Confidence 0.33 .567 0.04 .847 
     Nicotine Dependence (FTND) 0.79 .380 1.52 .218 
     Nicotine Dependence (WISDM) 1.38 .246 3.56 .060 
Personality     
     Neuroticism (Big Five) 3.22 .079 0.09 .759 
     Extraversion (Big Five) 0.10 .751 3.27 .071 
Impulsivity     
     Global Impulsivity (Barratt) 6.76 .012 1.01 .314 
     Risk-Taking Propensity (BART) 1.30 .260 1.18 .278 
Trait Motivation     
     Behavioral Inhibition (BISBAS) 3.44 .070 0.57 .452 
     Reward Response (BISBAS) 0.00 .973 22.40 < .001 
     Drive (BISBAS) 1.54 .221 11.92 < .001 
     Fun Seeking (BISBAS) 1.26 .267 14.87 < .001 
Cognitive     
     Cognitive Control (CFQ) 1.46 .233 3.80 .052 
     Working Memory (RS Trial) 0.00 .984 0.01 .926 
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Table 8. Associations between frontal asymmetry and smoking motivation 
 
 
 
 
 
 
 
Note. Effects that remain significant following FDR correction are bolded. 
  
 Main Effect Interaction 
 F P-value F P-value 
Internal State     
     Craving 7.02 .008 2.81 .094 
     Withdrawal 0.00 .987 5.77 .017 
     Positive Mood 0.60 .439 0.20 .657 
     Negative Mood 6.50 .011 2.68 .102 
Cigarette Ratings     
     Satisfaction 2.90 .089 0.03 .859 
     Psychological Reward 5.59 .019 2.83 .093 
     Craving Reduction 10.74 .001 0.54 .461 
     Respiratory Tract Sensations 3.40 .066 1.12 .290 
     Aversion 0.59 .441 0.13 .723 
Exposure     
     CO Boost 3.90 .049 4.64 .032 
Smoking Topography     
     Total Puff Volume 0.35 .556 1.45 .229 
     Average Puff Volume 7.40 .007 1.45 .229 
     Average Peak Flow Rate 3.49 .062 0.75 .388 
     Average Inter-puff Interval 9.88 .002 0.00 .990 
     Average Puff Duration 2.73 .099 0.51 .474 
     Number of Puffs 0.91 .340 2.16 .142 
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Table 9. Moderators of response time on reward prediction task 
Note. Effects that remained significant following FDR correction (done separately by column) are bolded.   
 Moderator Main Effect 
Moderator x 
Prediction 
Moderator x 
Reward 
Moderator x 
Prediction x 
Reward 
Moderator x 
Nicotine x 
Prediction 
Moderator x 
Nicotine x 
Reward 
Moderator x 
Nicotine x 
Prediction x 
Reward 
Moderator F P-value F P-value F P-value F P-value F P-value F P-value F P-value 
Demographic               
     Sex 0.31 .579 0.33 .563 6.30 .012 5.71 .017 1.65 .199 6.56 .010 0.05 .819 
     Race 0.24 .237 3.69 .055 4.31 .038 0.03 .865 2.92 .088 0.01 .917 0.16 .693 
     Ethnicity 0.00 .984 2.19 .139 1.00 .318 0.41 .520 0.00 .964 17.40 < .001 0.00 .950 
     Education Level 0.04 .838 0.06 .797 0.88 .347 0.11 .740 0.01 .942 2.26 .133 0.59 .443 
     Age 0.83 .386 1.77 .184 0.43 .514 0.21 .650 0.04 .851 0.13 .720 1.91 .167 
     Handedness 0.00 .992 0.83 .363 0.05 .820 0.38 .540 2.58 .108 0.14 .705 1.76 .185 
Smoking               
     Cigarettes per day 0.60 .442 18.40 < .001 0.40 .529 2.44 .118 2.79 .095 3.26 .071 0.14 .713 
     Age at first cigarette 0.35 .555 4.89 .027 11.41 .001 1.09 .297 6.77 .009 4.76 .029 0.03 .853 
     Motivation to quit 0.43 .514 0.23 .630 3.63 .057 0.19 .666 0.18 .668 0.66 .417 0.24 .625 
     Menthol smoker 0.00 .951 0.05 .827 5.87 .015 5.56 .018 6.70 .010 0.81 .367 3.51 .061 
     Quit History 0.30 .585 0.81 .369 1.84 .175 1.05 .306 0.37 .544 0.84 .359 1.86 .173 
     Quit Confidence 0.00 .961 0.05 .822 0.24 .624 0.03 .864 1.26 .262 0.80 .372 1.44 .230 
     Nicotine Dependence (FTND) 0.89 .350 2.18 .140 0.02 .691 0.00 .999 0.67 .413 3.04 .081 5.56 .018 
     Nicotine Dependence (WISDM) 0.54 .468 1.03 .310 0.77 .380 0.00 .982 0.31 .581 15.58 < .001 2.40 .121 
Personality               
     Neuroticism (Big Five) 1.31 .259 0.17 .683 5.98 .015 0.48 .488 0.27 .607 8.42 .004 1.23 .268 
     Extraversion (Big Five) 0.89 .352 0.29 .592 2.59 .108 5.57 .018 0.45 .503 12.42 < .001 0.12 .726 
Impulsivity               
     Global Impulsivity (Barratt) 0.93 .340 0.07 .793 2.34 .126 0.60 .439 0.15 .701 2.76 .097 1.71 .191 
     Risk-Taking Propensity (BART) 0.13 .719 6.19 .013 6.87 .009 1.32 .251 0.47 .495 4.00 .046 0.02 .897 
Trait Motivation               
     Behavioral Inhibition (BISBAS) 0.62 .434 3.24 .072 17.32 < .001 2.30 .130 0.59 .444 19.09 < .001 0.96 .328 
     Reward Response (BISBAS) 0.08 .778 3.12 .077 0.02 .876 1.43 .232 0.30 .585 0.39 .534 0.61 .437 
     Drive (BISBAS) 0.05 .822 2.16 .142 0.68 .410 0.13 .722 0.17 .681 0.40 .526 0.90 .342 
     Fun Seeking (BISBAS) 3.66 .062 0.36 .549 1.31 .252 0.40 .528 3.71 .054 0.06 .808 2.78 .095 
Cognitive               
     Cognitive Control (CFQ) 0.02 .884 1.02 .312 3.42 .064 0.22 .639 0.08 .781 2.59 .108 0.95 .329 
     Working Memory (RS Trial) 1.54 .220 0.03 .871 0..41 .521 4.01 .045 0.12 .728 0.44 .507 1.58 .209 
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Table 10. Moderators of MFN amplitude on reward prediction task 
Note. No effects reached significance following FDR correction (done separately by column).   
 Moderator Main Effect 
Moderator x 
Prediction 
Moderator x 
Reward 
Moderator x 
Prediction x 
Reward 
Moderator x 
Nicotine x 
Prediction 
Moderator x 
Nicotine x 
Reward 
Moderator x 
Nicotine x 
Prediction x 
Reward 
Moderator F P-value F P-value F P-value F P-value F P-value F P-value F P-value 
Demographic               
     Sex 1.69 .200 7.34 .007 0.70 .404 2.74 .099 1.49 .223 0.51 .478 0.75 .388 
     Race 0.10 .749 3.12 .078 0.89 .345 0.01 .936 2.84 .093 0.75 .388 1.29 .258 
     Ethnicity 0.30 .590 3.71 .055 0.21 .646 0.13 .722 0.97 .326 0.10 .751 0.09 .765 
     Education Level 0.60 .442 0.92 .340 0.11 .741 8.88 .003 0.56 .457 0.75 .387 2.89 .090 
     Age 1.83 .184 6.28 .013 0.07 .785 1.63 .202 0.54 .461 0.15 .703 0.35 .553 
     Handedness 0.34 .563 3.12 .078 0.72 .398 0.01 .943 0.37 .543 0.00 .994 0.07 .786 
Smoking               
     Cigarettes per day 0.81 .374 0.03 .875 0.47 .495 0.01 .906 0.16 .694 0.05 .820 0.00 .993 
     Age at first cigarette 0.42 .523 0.01 .924 0.48 .488 1.86 .174 0.00 .955 1.52 .219 0.15 .704 
     Motivation to quit 0.12 .732 1.97 .162 0.54 .464 2.31 .130 0.85 .357 1.19 .275 0.23 .630 
     Menthol smoker 0.00 .982 0.94 .333 0.69 .406 3.28 .071 0.48 .490 2.34 .127 0.87 .353 
     Quit History 0.41 .528 1.65 .199 0.00 .959 0.32 .573 0.25 .616 0.02 .897 0.20 .655 
     Quit Confidence 0.00 .976 0.01 .907 2.38 .124 3.06 .081 0.02 .890 1.64 .201 0.90 .344 
     Nicotine Dependence (FTND) 1.48 .230 0.22 .641 0.00 .966 3.04 .083 0.02 .877 0.01 .931 0.54 .463 
     Nicotine Dependence (WISDM) 0.53 .472 0.02 .885 0.00 .977 0.32 .574 0.01 .904 0.05 .819 0.56 .457 
Personality               
     Neuroticism (Big Five) 0.01 .922 0.52 .473 0.58 .449 0.29 .590 0.11 .739 0.06 .806 0.13 .715 
     Extraversion (Big Five) 0.14 .708 0.80 .373 0.37 .546 2.10 .149 0.02 .882 0.00 .988 0.12 .733 
Impulsivity               
     Global Impulsivity (Barratt) 0.01 .915 2.13 .146 0.02 .897 0.92 .337 0.02 .901 0.58 .448 0.56 .457 
     Risk-Taking Propensity (BART) 0.00 .972 0.90 .345 0.98 .323 0.33 .565 0.32 .573 0.10 .758 0.00 .952 
Trait Motivation               
     Behavioral Inhibition (BISBAS) 0.00 .990 4.04 .045 1.08 .301 0.85 .358 1.36 .244 1.26 .262 0.15 .704 
     Reward Response (BISBAS) 0.03 .875 3.60 .059 0.00 .947 0.67 .413 0.44 .509 0.04 .851 0.03 .872 
     Drive (BISBAS) 1.19 .281 0.07 .789 1.31 .254 0.03 .869 0.14 .713 0.16 .691 0.48 .489 
     Fun Seeking (BISBAS) 1.68 .201 2.52 .113 0.25 .616 1.22 .271 0.01 .917 0.13 .723 0.23 .633 
Cognitive               
     Cognitive Control (CFQ) 0.45 .507 3.00 .084 0.39 .532 0.62 .430 0.57 .453 1.30 .255 0.43 .510 
     Working Memory (RS Trial) 0.50 .482 0.92 .339 0.29 .591 0.05 .816 0.15 .703 0.04 .840 0.06 .803 
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Table 11. Associations between response time on the reward prediction task and smoking motivation 
Note. Effects that remained significant following FDR correction (done separately by column) are bolded.   
  
 Moderator Main Effect 
Moderator x 
Prediction 
Moderator x 
Reward 
Moderator x 
Prediction x 
Reward 
Moderator x 
Nicotine x 
Prediction 
Moderator x 
Nicotine x 
Reward 
Moderator x 
Nicotine x 
Prediction x 
Reward 
Moderator F P-value F P-value F P-value F P-value F P-value F P-value F P-value 
Internal States               
     Craving 5.75 .016 2.61 .106 0.01 .932 0.00 .958 1.23 .268 13.47 < .001 0.83 .362 
     Withdrawal 15.48 < .001 0.29 .593 3.56 .058 0.20 .656 0.45 .502 9.88 .002 0.33 .566 
     Positive Mood 17.58 < .001 2.67 .102 0.91 .341 0.20 .658 0.40 .526 0.65 .419 15.00 < .001 
     Negative Mood 3.44 .064 2.80 .095 12.98 < .001 1.19 .275 8.63 .003 11.77 .001 0.05 .830 
Cigarette Ratings               
     Satisfaction 263.52 < .001 2.29 .130 0.27 .603 1.60 .205 1.45 .228 17.69 < .001 2.02 .156 
     Psychological Reward 29.21 < .001 11.34 < .001 1.07 .302 0.35 .555 0.00 .975 6.88 .009 0.03 .862 
     Craving Reduction 11.09 .001 1.98 .159 2.98 .085 0.85 .355 1.73 .189 12.67 < .001 0.60 .437 
     Respiratory Tract Sensations 19.66 < .001 7.20 .007 1.72 .190 0.02 .887 0.00 .963 6.77 .009 0.85 .356 
     Aversion 37.20 < .001 3.18 .074 0.37 .543 3.10 .078 2.69 .101 0.41 .522 0.01 .941 
Exposure               
     CO Boost 26.11 < .001 0.46 .496 12.13 < .001 0.17 .678 0.02 .886 0.10 .752 0.75 .388 
Smoking Topography               
     Total Puff Volume 169.32 < .001 3.53 .060 2.06 .151 0.62 .431 2.90 .089 0.00 .997 3.99 .046 
     Average Puff Volume 298.21 < .001 3.37 .066 0.70 .404 0.92 .338 2.49 .114 0.85 .358 3.62 .057 
     Average Peak Flow Rate 164.04 < .001 1.10 .293 1.51 .220 0.79 .375 0.01 .910 0.22 .638 5.48 .019 
     Average Inter-Puff Interval 2.79 .095 5.44 .020 0.62 .430 0.03 .855 7.58 .006 3.28 .070 1.28 .258 
     Average Puff Duration 148.50 < .001 1.14 .285 3.58 .059 0.09 .767 2.26 .133 0.54 .461 0.05 .820 
     Total Puffs 63.29 < .001 0.31 .575 0.24 .623 0.01 .945 1.27 .259 1.75 .186 0.95 .329 
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Table 12. Associations between MFN amplitude on the reward prediction task and smoking motivation 
Note. Effects that remained significant following FDR correction (done separately by column) are bolded.   
 Moderator Main Effect 
Moderator x 
Prediction 
Moderator x 
Reward 
Moderator x 
Prediction x 
Reward 
Moderator x 
Nicotine x 
Prediction 
Moderator x 
Nicotine x 
Reward 
Moderator x 
Nicotine x 
Prediction x 
Reward 
Moderator F P-value F P-value F P-value F P-value F P-value F P-value F P-value 
Internal States               
     Craving 0.03 .864 0.08 .778 0.43 .511 0.10 .753 0.64 .425 0.04 .839 1.71 .193 
     Withdrawal 0.39 .535 0.13 .720 2.10 .148 0.01 .930 0.52 .472 0.00 .992 1.56 .209 
     Positive Mood 6.03 .015 2.51 .115 0.29 .591 2.94 .088 2.91 .089 0.05 .824 3.38 .067 
     Negative Mood 2.95 .087 1.02 .313 0.07 .788 1.03 .312 0.07 .793 0.22 .642 1.34 .248 
Cigarette Ratings               
     Satisfaction 5.87 .016 0.00 .967 0.24 .628 2.43 .120 0.02 .885 0.60 .440 1.45 .229 
     Psychological Reward 11.71 .001 0.52 .473 0.84 .361 0.16 .687 0.49 .483 0.56 .455 1.97 .162 
     Craving Reduction 0.86 .353 0.00 .957 0.18 .669 0.18 .672 0.02 .888 0.10 .748 1.07 .302 
     Respiratory Tract Sensations 4.09 .044 0.08 .782 0.06 .804 1.53 .217 0.44 .509 0.02 .900 4.08 .044 
     Aversion 1.60 .206 0.55 .461 0.55 .458 0.36 .552 0.71 .400 0.14 .711 0.34 .561 
Exposure               
     CO Boost 8.72 .003 0.40 .526 0.43 .515 1.34 .249 0.27 .603 1.27 .261 0.16 .691 
Smoking Topography               
     Total Puff Volume 9.49 .002 1.05 .306 1.10 .295 0.06 .814 0.70 .404 0.26 .609 0.75 .386 
     Average Puff Volume 4.97 .026 0.56 .453 0.06 .807 0.07 .794 1.17 .280 0.06 .810 0.08 .777 
     Average Peak Flow Rate 2.62 .106 1.38 .241 0.56 .457 0.32 .571 0.06 .809 0.53 .466 0.92 .339 
     Average Inter-Puff Interval 6.76 .010 0.92 .337 0.32 .570 0.04 .835 0.35 .552 0.02 .892 0.07 .788 
     Average Puff Duration 1.37 .243 0.01 .916 0.46 .498 0.10 .748 1.01 .315 0.15 .696 0.68 .409 
     Total Puffs 2.60 .108 0.05 .831 0.00 .968 0.00 .948 0.56 .453 0.18 .676 0.34 .561 
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Table 13. Moderators of accuracy on probabilistic learning task 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. No effects remained significant following FDR correction  
   Choose A Avoid B  
 Moderator Main Effect 
Moderator x 
Trial Type 
Moderator x 
Nicotine 
Moderator x 
Nicotine 
Moderator x 
Nicotine x 
Trial Type 
Moderator F P-value F P-value F P-value F P-value F P-value 
Demographic           
     Sex 4.86 .033 0.00 .959 0.08 .776 0.33 .572 0.03 .875 
     Race 0.91 .344 1.43 .235 0.00 .979 2.46 .125 0.62 .432 
     Ethnicity 1.38 .247 0.44 .510 0.39 .537 0.00 .959 0.21 .645 
     Education Level 0.00 .994 0.88 .350 6.68 .015 1.92 .174 6.18 .015 
     Age 1.74 .195 0.70 .404 0.03 .862 0.04 .847 0.00 .956 
     Handedness 0.23 .633 0.08 .774 0.74 .397 0.74 .396 1.33 .253 
Smoking           
     Cigarettes per day 1.50 .224 0.31 .579 0.00 .973 0.11 .747 0.01 .938 
     Age at first cigarette 7.38 .010 0.25 .617 0.03 .870 7.23 .012 2.50 .117 
     Motivation to quit 0.17 .687 0.32 .574 0.04 .840 0.01 .933 0.01 .915 
     Menthol smoker 1.72 .197 0.08 .784 0.01 .915 0.80 .375 0.10 .752 
     Quit History 0.02 .891 2.79 .098 2.86 .102 0.16 .692 0.51 .477 
     Quit Confidence 0.10 .753 6.35 .013 0.40 .549 2.87 .099 0.57 .451 
     Nicotine Dependence (FTND) 0.25 .622 2.95 .089 4.27 .048 8.18 .007 9.26 .003 
     Nicotine Dependence (WISDM) 0.34 .562 0.78 .380 1.71 .204 1.31 .261 2.33 .131 
Personality           
     Neuroticism (Big Five) 0.18 .675 2.64 .107 0.39 .537 0.51 .480 0.46 .499 
     Extraversion (Big Five) 0.92 .343 4.34 .040 0.14 .710 0.54 .465 0.46 .497 
Impulsivity           
     Global Impulsivity (Barratt) 0.04 .853 4.90 .029 1.58 .218 0.01 .908 0.45 .502 
     Risk-Taking Propensity (BART) 0.00 .988 0.64 .426 0.15 .701 0.43 .515 0.12 .728 
Trait Motivation           
     Behavioral Inhibition (BISBAS) 0.18 .723 2.77 .099 0.78 .383 2.25 .142 0.09 .763 
     Reward Response (BISBAS) 1.22 .277 7.29 .008 0.19 .669 0.95 .337 0.16 .690 
     Drive (BISBAS) 0.21 .652 1.70 .196 0.00 .995 2.43 .130 0.52 .474 
     Fun Seeking (BISBAS) 0.21 .653 0.18 .669 0.72 .407 0.04 .854 0.16 .687 
Cognitive           
     Cognitive Control (CFQ) 1.20 .278 6.53 .012 0.05 .823 0.00 .963 0.02 .893 
     Working Memory (RS Trial) 0.00 .967 0.40 .526 6.34 .017 3.40 .073 7.64 .007 
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Table 14. Moderators of FRN amplitude on probabilistic learning task 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. No effects remained significant following FDR correction  
 Moderator Main Effect 
Moderator x 
Feedback  
Moderator x 
Nicotine 
Moderator x 
Nicotine x 
Feedback 
Moderator F P-value F P-value F P-value F P-value 
Demographic         
     Sex 0.14 .706 0.11 .737 1.31 .255 0.02 .887 
     Race 0.08 .778 0.17 .681 1.28 .259 0.01 .927 
     Ethnicity 4.19 .047 0.25 .617 8.44 .004 0.16 .688 
     Education Level 1.04 .313 0.31 .581 0.07 .792 0.06 .802 
     Age 0.01 .915 2.75 .100 1.02 .315 0.21 .652 
     Handedness 0.04 .843 0.01 .906 0.93 .337 0.00 .971 
Smoking         
     Cigarettes per day 0.42 .521 0.09 .762 0.62 .432 0.15 .698 
     Age at first cigarette 3.08 .086 0.13 .715 5.19 .024 0.01 .906 
     Motivation to quit 0.15 .706 0.15 .697 0.39 .532 0.00 .976 
     Menthol smoker 0.50 .485 1.54 .217 2.42 .122 0.05 .827 
     Quit History 1.06 .309 0.32 .575 0.04 .846 0.15 .697 
     Quit Confidence 0.36 .551 0.50 .480 0.00 .956 0.06 .810 
     Nicotine Dependence (FTND) 3.41 .071 0.76 .385 1.50 .223 0.02 .883 
     Nicotine Dependence (WISDM) 2.11 .154 0.72 .398 0.37 .542 0.00 .959 
Personality         
     Neuroticism (Big Five) 0.02 .897 1.06 .305 0.00 .959 0.42 .521 
     Extraversion (Big Five) 0.01 .924 0.70 .405 0.00 .998 0.00 .985 
Impulsivity         
     Global Impulsivity (Barratt) 1.18 .283 0.32 .571 1.08 .301 0.01 .913 
     Risk-Taking Propensity (BART) 0.01 .907 0.14 .714 5.52 .020 0.31 .581 
Trait Motivation         
     Behavioral Inhibition (BISBAS) 0.01 .916 0.11 .744 2.09 .151 0.24 .623 
     Reward Response (BISBAS) 0.19 .666 1.34 .249 0.29 .588 0.13 .717 
     Drive (BISBAS) 0.00 .953 0.01 .914 0.45 .505 0.00 .950 
     Fun Seeking (BISBAS) 0.75 .392 0.37 .542 0.01 .942 0.00 .980 
Cognitive         
     Cognitive Control (CFQ) 0.57 .456 0.06 .810 0.55 .460 0.00 .998 
     Working Memory (RS Trial) 0.04 .850 0.80 .373 0.20 .656 0.01 .905 
52 
Table 15. Associations between accuracy on the probabilistic learning task and smoking motivation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Effects that remained significant following FDR correction (done separately by column) are bolded.    
   Choose A Avoid B  
 Moderator Main Effect 
Moderator x 
Trial Type 
Moderator x 
Nicotine 
Moderator x 
Nicotine 
Moderator x 
Nicotine x 
Trial Type 
Moderator F P-value F P-value F P-value F P-value F P-value 
Internal States           
     Craving 2.28 .137 0.03 .864 5.64 .022 1.43 .238 5.41 .022 
     Withdrawal 2.16 .148 0.68 .411 4.38 .043 6.05 .018 10.54 .002 
     Positive Mood 0.18 .671 0.45 .504 0.09 .765 0.01 .913 0.02 .903 
     Negative Mood 0.58 .451 1.88 .174 0.38 .542 0.06 .807 0.00 .956 
Cigarette Ratings           
     Satisfaction 0.13 .720 0.36 .552 6.21 .021 4.30 .046 6.36 .013 
     Psychological Reward 0.45 .506 0.12 .728 3.58 .069 0.51 .480 1.68 .199 
     Craving Reduction 0.59 .444 0.04 .849 0.43 .516 0.60 .442 0.91 .342 
     Respiratory Tract Sensations 0.08 .775 0.15 .704 4.00 .056 0.40 .533 1.32 .254 
     Aversion 1.66 .204 0.54 .462 2.15 .153 1.60 .213 2.50 .117 
Exposure           
     CO Boost 3.32 .074 1.64 .204 0.75 .392 0.94 .337 0.01 .934 
Smoking Topography           
     Total Puff Volume 0.03 .863 1.23 .271 0.01 .943 1.26 .267 0.05 .817 
     Average Puff Volume 0.03 .871 2.90 .092 0.56 .460 2.05 .159 1.28 .261 
     Average Peak Flow Rate 4.88 .034 3.77 .055 0.05 .817 1.14 .291 0.31 .579 
     Average Inter-Puff Interval 0.01 .909 1.73 .192 1.27 .270 1.38 .248 2.17 .145 
     Average Puff Duration 1.21 .276 0.04 .848 0.35 .559 0.42 .518 0.17 .685 
     Total Puffs 0.00 .958 2.33 .130 0.15 .700 0.02 .894 0.03 .862 
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Table 16. Associations between FRN amplitude and smoking motivation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. No effects remained significant following FDR correction.  
 Moderator Main Effect 
Moderator x 
Feedback 
Moderator x 
Nicotine  
Moderator x 
Feedback x 
Nicotine 
Moderator F P-value F P-value F P-value F P-value 
Internal States         
     Craving 0.72 .396 0.07 .792 2.31 .131 0.20 .655 
     Withdrawal 0.02 .885 0.15 .697 1.97 .161 0.06 .807 
     Positive Mood 2.16 .145 0.03 .859 0.71 .400 0.01 .913 
     Negative Mood 0.01 .933 0.19 .663 1.25 .265 0.03 .854 
Cigarette Ratings         
     Satisfaction 6.43 .013 0.45 .506 0.02 .898 0.21 .651 
     Psychological Reward 7.49 .007 0.82 .368 6.74 .011 0.04 .850 
     Craving Reduction 4.73 .031 0.01 .916 0.02 .895 0.25 .617 
     Respiratory Tract Sensations 1.40 .239 0.44 .508 0.07 .792 0.09 .764 
     Aversion 5.94 .016 0.16 .694 2.45 .120 0.11 .740 
Exposure         
     CO Boost 0.04 .844 0.12 .732 0.05 .820 0.16 .692 
Smoking Topography         
     Total Puff Volume 1.28 .260 0.86 .356 0.26 .612 0.06 .810 
     Average Puff Volume 0.22 .637 2.56 .110 0.01 .945 0.05 .821 
     Average Peak Flow Rate 10.68 .001 0.79 .375 2.46 .119 0.87 .353 
     Average Inter-Puff Interval 0.10 .752 0.42 .518 1.29 .259 0.00 .970 
     Average Puff Duration 0.64 .426 0.62 .434 0.04 .849 0.02 .894 
     Total Puffs 0.87 .353 0.73 .394 0.01 .931 0.03 .866 
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Discussion 
Overall, results of the present study support the notion that nicotine withdrawal impacts 
motivational and reward systems in humans. A detailed discussion of results for each of the 
primary outcome variables is presented in separate sections below.  However, generally 
speaking, hypotheses regard the effects of nicotine withdrawal on frontal asymmetry were 
confirmed and numerous moderators were identified, providing a framework to guide future 
research on the role of individual differences in the experience of nicotine withdrawal. Critically, 
frontal asymmetry was also strongly related to indices of smoking motivation, suggesting that 
broad shifts in motivational state as indexed by frontal asymmetry may play an important role in 
driving behavior. However, results from the reward prediction and probabilistic learning task 
were significantly more convoluted and generally did not support a priori hypotheses. Nicotine 
withdrawal produced a robust decrease in MFN amplitude, but this effect was comparable across 
all trial types. Thus, its significance is largely unknown. However, significant effects on behavior 
during the task (i.e. time to initiate next trial following feedback) were observed, indicating that 
nicotine withdrawal may indeed impact reward processing, just not via traditional pathways 
studied using this task.  Nicotine withdrawal did not appear to impact behavior during the testing 
phase of the probabilistic learning task.  As with the MFN, a robust effect of withdrawal on FRN 
amplitude during the training phase was observed, but the lack of an interaction with trial type 
diminishes its interpretive meaning. Regardless, results suggest that whatever impact nicotine 
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withdrawal may have on feedback learning may be transient and unlikely to lead to significant 
adaptations in future behavior.  
Motivational State 
As noted above, frontal asymmetry results from the present study were largely consistent 
with hypotheses. Nicotine withdrawal produced a leftward shift in frontal alpha power (or 
alternatively, a rightward shift in cortical activation). This is consistent with well-established 
findings for depression (e.g. Allen & Cohen, 2010; Allen & Kline, 2004; Coan & Allen, 2004) 
and provides some evidence to suggest that the neurobiological similarities between nicotine 
withdrawal and depression observed in animals can justifiably be extended to human research 
(Markou et al., 1998). Given the increased emphasis on transdiagnostic models of 
psychopathology and identifying links between disorders, such as the Research Domain Criteria 
(RDoC) put forth by the National Institutes of Health (Cuthbert & Insel, 2013; Insel et al., 2010; 
Woody & Gibb, 2015), further exploration of this finding as a potential mechanism linking 
nicotine dependence and depression is warranted. Numerous moderators of this effect were also 
present. The effect was present among men but not women, which could plausibly be attributed 
to the oft-repeated assertion that smoking among men is driven principally by physiological (vs. 
social) factors (Perkins et al., 1999). However, other explanations remain equally plausible, as 
sex may merely be associated with a host of other variables that have a more direct relationship 
with frontal asymmetry effects. Thus, caution is urged regarding interpretation of this effect at 
the present time.  
The fact that nicotine withdrawal produced a more robust leftward shift in frontal alpha 
among those who report higher trait approach motivation suggests this is a potentially critical 
risk factor. Prior research indicates frontal asymmetry correlates with trait approach motivation 
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(Coan & Allen, 2003; Sutton & Davidson, 1997) and that high approach motivation renders 
individuals more likely to engage in smoking or other drug use behaviors (O’Connor, Stewart, & 
Watt, 2009). As results from the present study indicate high approach motivation also renders 
individuals more susceptible to a potentially adverse effect of withdrawal (perhaps due to having 
“more to lose” from a motivational standpoint), this construct of approach motivation may 
indeed play a profound role in the onset and maintenance of smoking behavior. Also noteworthy 
is that the effects of nicotine withdrawal on frontal asymmetry was strongest among those who 
had never before attempted to quit and had relatively lower levels of motivation to quit. If 
withdrawal truly induces a state of cortical activation similar to depression, it is plausible that it 
may include feelings of helplessness/hopelessness and a corresponding reduction in effort to 
modify behavior. Alternatively, the shift observed in response to nicotine withdrawal could 
represent an underlying vulnerability to depression – a view that is consistent with the capability 
model of frontal asymmetry to the degree that one assumes nicotine withdrawal reflects a 
neurobiological “challenge” to emotional systems (Coan, Allen, & McKnight, 2006). Regardless, 
results support the notion that nicotine withdrawal has a robust impact on global motivational 
indices such as frontal alpha wave asymmetry. Further exploration of these findings and the role 
they may play in smoking behavior may inform the development of novel interventions and our 
understanding of the neural mechanisms responsible for smoking motivation. 
Reward Sensitivity 
Findings for the reward prediction task were somewhat consistent with the notion that 
nicotine withdrawal impacts immediate reward processing. As noted above, a main effect of 
nicotine withdrawal on MFN amplitude was observed. However, the absence of a significant trial 
type interaction renders the meaning of this effect difficult to interpret. To the degree one 
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assumes MFN amplitude does reflect dopaminergic response within the VTA, these results may 
reflect a global blunting of dopaminergic activity within this region that is relatively independent 
of whatever active processing may be occurring. Though not precisely how the impact of 
nicotine withdrawal has traditionally been conceptualized in animal models, it is nonetheless 
consistent with the results of some prior research (Kenny & Markou, 2001). The significant 
associations between MFN amplitude (independent of trial type) and several indices of smoking 
motivation also provide some support for this viewpoint. 
   Despite the above findings, nicotine withdrawal did appear to have meaningful and 
specific effects on behavior during the task. Individuals were slower to initiate the next trial 
following presentation of an unexpected non-reward during periods of nicotine withdrawal, 
potentially reflecting heightened frustration in response to an expected reward not being 
delivered and/or a potential reluctance to reengage in reward-seeking behavior following a loss. 
Responses following unexpected reward trials were slowed relative to other trial types regardless 
of withdrawal status. These results are generally consistent with other research documenting 
differences in reward-seeking and decision-making brain activation among smokers undergoing 
nicotine withdrawal (Addicott et al., 2012) and are particularly noteworthy since, to the best of 
our knowledge, no previous research using this task has examined response time. Present results 
suggest it may be a more sensitive index than neural measures on this task, at least with regards 
to the effects of nicotine withdrawal. 
A number of moderators of response time effects were present. In contrast to frontal 
asymmetry results, withdrawal facilitated (speeded) responses following reward trials for men, 
but slowed responses to these trials for women. However, this effect for men may have been 
driven largely by individuals of Hispanic descent who exhibited very robust facilitation of 
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responding during placebo sessions. Unfortunately, there were no women of Hispanic descent in 
the present sample so this intersection cannot be explored statistically. Regardless, these effects 
should be interpreted cautiously given the relatively limited sample size of each subgroup. In 
addition to findings for demographic variables, high levels of nicotine dependence or 
neuroticism appeared to be risk factors for exhibiting slowed response times on reward trials 
during nicotine withdrawal, whereas high levels of extraversion or behavioral inhibition were 
relatively protective.  Individuals with higher levels of nicotine dependence or neuroticism 
appeared to be at greatest risk of experiencing these effects, whereas the opposite pattern was 
observed for individuals with high levels of extraversion or behavioral inhibition.  
Together, the above findings indicate a significant role for individual differences in 
reward processing/behavioral response to rewards. The well-established association between 
smoking and negative affect (Kassel, Stroud, & Paronis, 2003) may be partially explained by a 
linkage of the reward processing deficits within this population. When coupled with numerous 
robust associations between indices of smoking motivation and response time following reward 
trials during placebo sessions, this suggests that alterations in reward processing may play a 
pronounced role in motivating smoking behavior. As smoking offers a reliable reward from a 
neurobiological perspective (Benowitz, 2008), it seems logical that it would prove a more 
attractive option during times when nicotine withdrawal precluded normal reward processing and 
interfered with the processing of alternate rewards.  
Feedback Learning       
Unlike findings for frontal asymmetry and reward processing, there was only minimal 
evidence to suggest that nicotine withdrawal affected performance on the feedback learning task. 
As with the MFN, we did observe a main effect of withdrawal on the FRN with participants 
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exhibiting more negative FRNs to both correct and incorrect feedback during withdrawal. Again, 
this is generally consistent with a global reduction in dopaminergic activity during withdrawal, 
though relies heavily on a number of assumptions and theories regarding the neural generators of 
the FRN that itself remains an evolving area of research (Hauser et al., 2014). None of the 
moderators tested appeared to impact this effect, nor was there any evidence to support an 
association between FRN amplitude and smoking motivation. 
There was also only minimal evidence to support any effects of nicotine withdrawal on 
behavioral performance during the testing phase of the task. No moderators of behavioral 
performance on this task survived FDR correction. However, it should be noted that several 
variables of substantial theoretical importance (i.e. nicotine dependence, education, working 
memory) narrowly missed this threshold and did have significant uncorrected p-values. Also 
cause for some level of optimism was the significant interaction between self-reported 
withdrawal, nicotine contents and testing trial type, as the hypothesized effects did appear to be 
present among those with higher levels of self-reported withdrawal. Thus, it seems premature to 
definitively conclude that nicotine withdrawal does not impact approach and avoidance learning. 
Rather, these effects may merely be weaker or more highly dependent on individual differences. 
It should be noted that much of the prior research using this task has been done on individuals 
with substantially higher levels of educational attainment than the sample of the present study 
(e.g. Frank et al., 2004). Limited understanding of the task or frustration with performance on the 
task may have obscured effects. Given the relative complexity of the task and the sheer number 
of cognitive processes involved in feedback learning relative to the other constructs assessed in 
this study, it seems reasonable to assume that greater noise would be present in behavioral 
performance on this task, thus rendering experimental effects more difficult to observe. Future 
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research should take this into account either by recruiting larger samples, employing a more 
robust manipulation of withdrawal or using alternative tasks. Lastly, it should be noted that 
although the focus of the present study was on neural responses to feedback during training and 
testing performance, this task allows for extraction of numerous other indices (e.g. learning 
trajectories during training, high-conflict vs. low-conflict learning, win-stay vs. lose-shift 
learning strategies) that may warrant further exploration.  
Limitations 
Foremost among the limitations of the present study are the relatively small sample size. 
Although the n of the present study was equal or larger than most studies of this type (e.g. Barr et 
al., 2008; Dawkins et al., 2007; Potts, Bloom, Evans, & Drobes, 2014) and power was further 
enhanced through the use of a within-subjects design, the stability of the parameter estimates and 
generalizability to the broader population of smokers is nonetheless a limitation. This concern is 
multiplied for analyses that examined individual differences variables (i.e. moderators of 
experimental effects, association of experimental effects with smoking motivation variables) and 
replication within larger samples is needed before any firm conclusions are drawn. Also 
noteworthy is that the present study employed careful screening procedures that significantly 
restricted the sample (e.g. eliminating potential participants with the most commonly comorbid 
psychopathologies). Though arguably appropriate for the current stage of research, this again 
raises questions about the generalizability of the results observed herein. Results could differ 
significantly when comorbid psychopathologies are included, as competing effects or 
interactions may overwhelm any direct effects of nicotine withdrawal.  
The double-blind smoking procedure that was employed for studying nicotine withdrawal 
carries advantages for internal validity, but also precluded a refined assessment of the temporal 
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course of nicotine withdrawal. Evidence suggests that some withdrawal symptoms emerge within 
30 minutes (Hendricks et al., 2006) and can last for several weeks to several months (Hughes, 
Higgins, & Bickel, 1994). The effects in the present study clearly emerged overnight, but it is 
unknown the degree to which similar effects would be observed earlier or later in the withdrawal 
process. Although a number of associations between motivational state, reward sensitivity and 
smoking motivation were observed, it is unknown whether these findings actually extend to 
impact actual smoking behavior. In light of recent criticisms levied at other areas of study within 
the tobacco use field (Perkins, 2009), it is acknowledged that the clinical relevance of the present 
findings hinges on the assumption that these effects are predictive of ongoing smoking behavior 
or relapse following a quit attempt. Though associations with numerous indices of motivation 
were observed, it is premature to assume that this extends to actual smoking behavior and this 
remains an open empirical question.  An immediate future direction based on present findings 
includes examining the ability of these effects to prospectively predict smoking behavior from 
indices of reward processing during nicotine withdrawal, both within a laboratory context and in 
ecologically valid settings.  
Conclusions 
Overall, results of the present study support the notion that nicotine withdrawal has a 
profound impact on reward processes, while providing some clarity as to the specificity of these 
effects across diverse relevant systems. Changes in neural systems consistent with a global 
change in motivational state were observed (i.e. frontal asymmetry findings), while other results 
pointed to specific deficits in reward processing. Although there was minimal evidence for an 
effect of nicotine withdrawal on reward learning, it is nonetheless possible that these effects may 
impact behavioral choices. Looking back to the role of secondary reinforcement in driving 
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smoking behavior, results of the present study begin to illustrate how nicotine withdrawal may 
impact this process. Elevations in avoidance motivation and reward processing deficits may 
make individuals less inclined to pursue non-smoking rewards in their environment during bouts 
of withdrawal. Over time this behavior may become a pattern, exacerbating smoking and 
diminishing the relative value ascribed to unrelated activities. This process could well occur in 
conjunction with enhanced incentive value of nicotine (Robinson & Berridge, 2008), with an 
aggregated effect of dramatically increasing the likelihood of engaging in smoking behavior.  
As noted by others (Leventhal, 2015), motivation to engage in a behavior cannot be 
understood in isolation. The impact that smoking and nicotine withdrawal may have on 
motivation and the processing of alternative rewards is critical for understanding why individuals 
may be motivated to smoke…whether it is due to the expected reward to be derived from 
smoking or the relative lack of reward that can be derived from alternate sources. The study 
provides an initial foray into this topic within humans, but it nonetheless remains a relatively 
understudied area. Studies across neurobiological, pharmacological, behavioral and sociological 
levels of analysis are needed to derive the maximal clinical utility from this line of research.    
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